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Abstract 
Anterior cruciate ligament (ACL) deficiency results in knee instability that includes an 
increase in internal tibial rotation and anterior tibial translation (ATT) as ACL is the 
primary restraint to anterior shear and internal rotation.  Clinically, ACL deficient (ACLD) 
patients undergo surgery or/and rehabilitation programmes depending on their ability to 
cope or otherwise. However, the ACL reconstructed (ACLR) knees may still have residual 
instability in ATT and tibial internal rotation.  Functional electrical stimulation (FES) has 
been used in conventional physiotherapy for ACL deficiency, including strengthening the 
muscles around the knee. The rehabilitation treatment focuses on strengthening the 
quadriceps muscle because it gets weakened after ACL injury or ACL reconstruction. 
However, stimulating the hamstrings, especially the biceps femoris long head (BFLH) with 
its insertion on the fibular head is a candidate to reduce the knee instability of ACLD and 
ACLR by applying a posterior pull and external rotation to the tibia. This thesis proposes 
that knee instability in ACLD subjects can be reduced by stimulating the BFLH muscle 
with FES. Here, a musculoskeletal modelling approach was used to simulate the function 
of FES. A new optimisation method was developed which allowed the inclusion of FES. 
There are three main studies present in this thesis. First, a pilot study was conducted in 
which healthy control subjects walked with and without FES of BFLH. It was found that 
selective activation of the BFLH can reduce the anterior tibial shear and tibial internal 
rotation torque at the knee in healthy subjects. Second, a validation study for the algorithm 
used in the musculoskeletal model was conducted in which the effect of FES stimulation of 
the BFLH on gluteus maximus activations was tested using electromyography (EMG). 
This study concluded that there were statistical correlations between peak and impulse of 
gluteus maximus activation between FES activation level and muscle activity of gluteus 
maximus as quantified by both EMG and the musculoskeletal model. In the final study, the 
validated model was used to compare the internal rotation torque, anterior shear force, 
speed and gluteus medius and gluteus maximus muscle activation between control, ACLD 
and ACLR groups during stance phase with and without FES stimulated on BFLH. This 
study found that the activation of BFLH with FES during stance phase was able to reduce 
the knee instability of the patient groups and triggered the compensatory mechanism for 
each patient group to react differently. Therefore, besides quadriceps, the rehabilitation 
treatment should focus on appropriate timed activation of the BFLH to improve the quality 
of life of patients.  
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CHAPTER 1  
Thesis Motivation and Scope 
This chapter provides a general overview of the subject matter of this thesis and provides 
the thesis aim, scope and structure. 
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1.1 Problem Statement and Motivation 
Anterior cruciate ligament (ACL) injury is one of the most common types of knee injuries 
which occur to both men and women, especially to those active in sport.  ACL injury 
causes knee instability mainly in anterior tibial translation (ATT) and internal rotation. 
ACL deficient patients can be divided into copers and non-copers. Coping is achieved by 
avoiding muscular contraction that produces an anterior shear force, for example, avoiding 
full contraction of the quadriceps especially during the early stance phase and when the 
knee is at full extension (Escamilla et al., 2012). An alternative coping mechanism 
counteracts quadriceps contraction through co-contraction of the hamstrings (Rudolph et 
al., 2001; Sinkjaer et al., 1991) and through the adaptation of muscle firing (Andriacchi et 
al., 2005).  The copers are able to return to pre-injury activity without surgical intervention 
and non-copers require surgery to achieve the same outcome. It has been reported that 44% 
of ACL reconstructed patients returned to sport (Ardern et al., 2011) and 24% of young 
people (10-25 years old) who had ACL reconstruction had a second ACL injury (Paterno et 
al., 2010). As the muscle interactions, especially quadriceps and hamstrings can help in 
improving knee stability, stimulating the right muscle at the right time is important.  
Enhancing muscle interactions and stimulation may help non-copers to become copers. 
Optimisation of muscle contraction through functional electrical stimulation (FES) offers 
the prospect of mitigating the destabilising effects of ACL deficiency.  
Most clinical studies have focused on strengthening the quadriceps muscles of ACL 
deficient patients with FES but these have overlooked the beneficial effect of activating the 
hamstrings. FES has been used to stimulate hamstrings, semitendinosus and biceps 
femoris, to reduce ATT, however, this was only used in healthy subjects and not ACL 
patients (Chen et al., 2013). The selection of semitendinosus is surprising, because it is 
located on the medial side of the knee and so is not positioned to help in reducing internal 
rotation torque.  Also, ACL reconstruction surgery mostly uses semitendinosus as a graft 
and consequently, the semitendinosus muscle becomes weaker after the surgery. However, 
stimulating the lateral hamstrings will result in a posterior pull and external rotation on the 
tibia. The biceps femoral long head (BFLH) is ideally placed to achieve this.  
However, the interplay between knee stabilisation and musculoskeletal system restraint 
with FES stimulating BFLH is not known for ACL deficient and ACL reconstruction 
patients. As such, the value of BFLH muscle activation, activated with FES which has the 
potential to reduce knee instability, needs to be investigate. A new musculoskeletal model 
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needs to be introduced to estimate the BFLH muscle contraction with FES; this could then 
be used to simulate and analyse ACL deficient patients focussing on their knee joint 
stability in the plane of articulation in order to include rotational and translational effects.  
Quantifying the level of muscle stimulation through FES is challenging as conventional 
recording of muscle activity using electromyography (EMG) is not possible to the 
stimulation artefacts. Previous studies removed the stimulation artefact by using a shut-
down circuit and an adaptive filter or extracted the volitional EMG from a partially 
paralyzed muscle and used this to control other muscle stimulation (Frigo et al., 2000; 
Thorsen et al., 1999). However, none of these have been able to totally eliminate FES 
artefacts from the EMG signals (Frigo et al., 2000; Sennels et al., 1997) or to control the 
EMG-controlled FES stimulation to stimulate only the targeted paretic muscle, or to negate 
the stimulation of other muscles located near to the paretic muscles (Thorsen et al., 1999).  
An alternative method needs to be introduced to solve this problem. Instead of designing a 
new device or system to extract the stimulation artefact, an alternative method to quantify 
FES stimulation could be conceived whereby the effect of FES stimulation of one muscle 
on the muscle activations of other muscles could be investigated. To date, no study has 
been able to adequately address this problem.  
1.2 Aim and Scope 
The aim of this study is to investigate the ability of FES stimulation of BFLH to reduce the 
knee instability of ACL deficient and ACL reconstructed patients by means of in vivo 
physical experiments and computational musculoskeletal modelling. 
1.3 Thesis Objectives 
The objectives of this thesis are to : 
a. formulate a musculoskeletal mathematical model to investigate the optimum 
levels of BFLH activation during FES gait in reducing the anterior shear force 
to zero; 
b. validate the musculoskeletal model in (a) that quantifies and evaluates the effect 
of FES on selected muscles through measuring EMG of muscles that are not 
affected by the FES stimulation artefact; and 
c. utilise this knowledge to enhance knee stability in the ACL deficient and ACL 
reconstructed groups by using FES. 
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1.4 Thesis Outline 
This thesis is subdivided into six chapters. 
Chapter 2 presents literature review on the musculoskeletal modelling, biomechanics of 
the ACL deficient and ACL reconstructed patients and its current treatment. 
Chapter 3 introduces the pre-study of musculoskeletal modelling on the ability of the FES 
stimulation of the BFLH of the healthy subjects in reducing the anterior shear force and 
internal tibial rotation torque.  
Chapter 4 explains the validation of the novel cost function to simulate neuromuscular 
electrical stimulation during gait. 
Chapter 5 compares the differences in kinematics between healthy, ACL deficient and 
ACL reconstructed groups in walking with and without FES stimulation of the BFLH by 
means of physical experiments and musculoskeletal modelling.  
Chapter 6 presents the overall discussion of this thesis and proposes future work. 
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CHAPTER 2  
Literature Review and Background   
This chapter presents a literature review on the functional anatomy of anterior cruciate 
ligament (ACL) deficient and ACL reconstructed patients and their current treatments. 
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2.1 Functional Anatomy of Anterior Cruciate Ligament (ACL) 
The anterior cruciate ligament (ACL) is located between the two condyles of the 
tibiofemoral joint and crosses the posterior cruciate ligament in an anterior-posterior 
direction (Figure 2.1 and Figure 2.2).  
 
Figure 2.1 Posterior aspect of a left knee (© Primal Pictures. All rights reserved. Primal Pictures, an informa 
business www.primalpictures.com www.anatomy.tv) highlighting the femoral origin of the anterior cruciate 
ligament. 
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Figure 2.2 Anterior aspect of a left knee (© Primal Pictures. All rights reserved. Primal Pictures, an informa 
business www.primalpictures.com www.anatomy.tv) highlighting the tibial insertion of the anterior cruciate 
ligament. 
The ACL origin is on the posterior part of the medial surface of the lateral femoral condyle 
and inserts on a wide depressed area in front of and lateral to the anterior tibial spine 
(medial intercondylar tubercle) with some variable fibers attached to the base of the spine 
(Girgis et al., 1975). The tibial spines are lodged in the intercondylar notch (Figure 2.3) 
(AM : anteromedial, PL : posterolateral). 
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Figure 2.3 Caudal view of tibial plateau of a right cadaveric specimen. The ACL insertion site is marked, and 
its relation with the medial tibial spine and anterior horn of the lateral meniscus is shown (The Journal of 
Arthroscopic & Related Surgery, Anatomic Single- and Double-Bundle Anterior Cruciate Ligament 
Reconstruction Flowchart, 26, 2010, page 263, Carola F. van Eck, Bryson P. Lesniak, Verena M. Schreiber, 
Freddie H. Fu. Copyright © 2010 Arthroscopy Association of North America. Published by Elsevier Inc. All 
rights reserved. "With permission of Springer") 
The tibiofemoral knee joint motion occurs in all three planes (sagittal, frontal and 
transverse) with six degrees of freedom (three rotations and three translations) between the 
femoral and tibial plateau (Figure 2.4) (Woo et al., 2006). The primary function of the 
ACL is to restraint anterior tibial translation (ATT) (Noyes et al., 1983b), where ATT 
occurs across a range of knee flexion angles, activities, and muscle activations. The 
secondary function of the ACL is to resist tibial internal rotation and varus rotations 
(adduction) (Gao et al., 2010; Logan et al., 2004b). 
The ACL has two functional portions which are the anteromedial (AMB) and 
posterolateral (PLB) bands. The terminology of the bundles is based on their tibial 
insertion. The AMB fibres originate on the most proximal part of the femoral origin and 
insert on the anteromedial aspect of the tibial insertion site. The PLB fibres originate on the 
most distal aspect of the femoral origin and insert on the posterolateral aspect of the tibial 
insertion site. The AMB is the more significant restraint to anterior tibial translation of the 
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knee (Girgis et al., 1975), while the PLB is an important restraint to tibial internal rotation 
of the knee (Yagi M, 2002). The load sharing between these two bands complement each 
other (Wu et al., 2009) to provide restraint across a large range of knee joint flexion. The 
distribution of strain between the bundles and over the cross section of the ACL is not 
uniform and depends on the position of the tibiofemoral joint, muscle contraction, and 
externally applied loads to the limb, in particular, ground reaction forces. When the knee is 
extended, the femoral attachment of the ACL is in a vertical position, the PLB is tight, and 
the AMB is moderately lax. In contrast, when the knee is flexed, the femoral attachment of 
the ACL becomes more horizontally orientated, causing the AMB to tighten and the PLB 
to loosen (Zantop et al., 2007).  
 
Figure 2.4 Rotation and translation motions of the knee joint (Sports Medicine, A ‘Plane’ Explanation of 
Anterior Cruciate Ligament Injury Mechanisms, Carmen E. Quatman et. al, 40, 2010, page 731, Copyright © 
2010, Adis Data Information BV "With permission of Springer") 
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The ACL can resist anterior tibial translation in response to a combined internal tibial 
torque and valgus torque; therefore, in response to this combined rotatory load, the knee 
undergoes anterior tibial subluxation when the ligament is deficient (Fukuda et al., 2003; 
Gabriel et al., 2004). 
The articular rotational motion of the knee occurs about the centre of the medial tibial 
plateau (Amis et al., 2005). Knee joint movements are not only related to the surface of the 
tibia but also muscle activity (Shelburne et al., 2004). Knee stability is achieved by a good 
collaboration between the primary active and the passive knee stabilizers, which are the 
muscles and the ligaments (Shelburne et al., 2005). 
2.2 Knee Muscles and the ACL 
Muscles that dynamically resist anterior tibial translation act as ACL agonists, whereas 
muscles that dynamically produce anterior tibial translation act as ACL antagonists (Elias 
et al., 2003). Because the hamstring muscles attach on the proximal tibia and exert a force 
with a posterior orientation when the knee is flexed, they are considered the primary ACL 
agonists (Li et al., 1999; MacWilliams et al., 1999; More et al., 1993), restraining ATT and 
reducing ACL strain (Li et al., 1999; Renstrom et al., 1986). Hamstrings can be divided 
into biarticular (semitendinosus, semimembranosus, and long biceps femoris) and 
monoarticular (short biceps femoris) knee flexor muscles that act on both the medial 
(semitendinosus and semimembranosus) and lateral (long biceps femoris and short biceps 
femoris) side of the joint (Figure 2.5). During knee flexion, the hamstrings activations 
moves the lateral part of the tibia more than the medial portion, because of its geometric 
location and because of the more mobile lateral tibial plateau (Kwak et al., 2000; Victor et 
al., 2010). Biceps femoris in particular assists in rotating the tibia externally when the knee 
is semi-flexed (between 20⁰ to 50⁰) (Besier et al., 2003).  
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Figure 2.5 Hamstring muscles (© Primal Pictures. All rights reserved. Primal Pictures, an informa 
business www.primalpictures.com www.anatomy.tv) 
Conversely, the quadriceps muscles are considered ACL antagonists; they are the strongest 
muscles across the knee and are attached through the quadriceps tendon to the patella.  The 
quadriceps has four main muscles namely the vastus lateralis, rectus femoris, vastus 
medialis, and vastus intermedius (Figure 2.6). As quadriceps contract, they extend the knee 
through apply a force to the patellar tendon. This applies an ATT and thus an intact knee 
will produce a force in the ACL when the quadriceps is contracted. 
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Figure 2.6 Quadriceps muscles (© Primal Pictures. All rights reserved. Primal Pictures, an informa 
business www.primalpictures.com www.anatomy.tv) 
2.3 Anterior Cruciate Ligament Deficiency (ACLD) 
ACL injury is prevalent especially in young athletes (Donnelly et al., 2012). ACL injury is 
commonly caused by non-contact injury (indirect force). The defining features of the non-
contact injury are that it results from the athlete’s own movements, which typically are 
disturbed by a physical or cognitive perturbation either during or immediately before the 
injury event (Marshall, 2010). ACL injury is clinically diagnosed through manipulating the 
knee to elicit translations and rotations that would normally be resisted by an intact ACL. 
The Lachman test applies an anterior drawer force to the tibia at 20° flexion which can 
then be diagnostic of an ACL injury if ATT is increased compared to a healthy knee. 
Combined rotational instability due to ACLD is tested with the “pivot shift test” which 
involves applying a combined internal tibial and valgus torque throughout the range of 
flexion-extension (Matsumoto, 1990). The pivot shift is then observed as a sudden 
combined rotation and translation motion that is not present in the healthy knee (Bull et al., 
1998). 
The mechanism of non-contact ACL injury typically involves multiplanar loading 
including anterior tibial shear force, knee abduction and internal or external tibial rotation 
Rectus femoris 
and Vastus 
intermedius 
Vastus 
medialis 
Vastus 
lateralis 
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moments (Figure 2.7) (Levine et al., 2013). More than half of the athletes injured their 
ACL during a sidestepping sport manoeuvre (Donnelly et al., 2012; Griffin et al., 2006). 
 
Figure 2.7 Multiplanar loading mechanism of a noncontact anterior cruciate ligament injury. Image 
reproduced with permission from Levine et al. (2013)  
Most ACLD patients are not able to return to sport, because of continued episodes of knee 
giving way (non-copers). The ACL injury can lead to severe disability affecting sporting 
activities (77%), routine activities (44%) and walking (31%) (Noyes et al., 1989). ACLD 
results in increased ATT and internal tibial rotation and therefore the secondary restraints 
are more highly loaded, for example, resistance to ATT is provided by the long superficial 
medial collateral ligament (MCL) (Masouros et al., 2010; Shelburne et al., 2004). This 
causes the secondary restraint to stretch and fail over time (Wen et al., 2000).  
Other changes to the joint occur due to ligament injury and these are particularly 
significant when loaded in gait (Dyrby et al., 2004; Shimokochi et al., 2008). These 
changes are not found during non-weightbearing activities (e.g. passive leg flexion). When 
the ACL is injured, the rotational axis moves further medial and thus there is a large 
translation of the lateral compartment (Amis et al., 2005; Georgoulis et al., 2003; Logan et 
al., 2004a). This is because the axis of rotation of the tibial plateau of ACL injury is no 
longer at the centre of the medial plateau, but at the outside of the medial tibial plateau 
(Amis et al., 2005; Bull et al., 2002).  
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This offset of internal tibial rotation axis has been observed in ACL deficient knees during 
walking (Andriacchi et al., 2005; Georgoulis et al., 2003) and also in ACL reconstructed 
knees (Gao et al., 2010). However, there is some literature that found the opposite in that 
the axis of rotation was on the lateral side during normal walking (Koo et al., 2008), 
however, these studies did not use the same methods or kinematics descriptions. In 
particularly the use of instantaneous rotational axes to describe the known combination of 
flexion, anterior–posterior translation and internal–external rotation that occur during 
walking (Dyrby et al., 2004) causes confusion in the literature. It is important to 
understand the movement strategies of ACL deficient subjects during the mid-stance phase 
of gait at which point these complex movements occur. 
The normal function of the knee requires a subtle balance between stability and mobility of 
the ligaments, joint surfaces and muscles spanning the joint (Dyrby et al., 2004; Koo et al., 
2008). When the ACL is ruptured, the mechanics of the knee joint are greatly altered by 
adaptive changes in patterns of gait.  For example, hamstring co-contraction, in addition to 
their primary role as knee flexors, providing synergistic action to the ACL by preventing 
excessive anterior displacement and internal rotation of the tibia (Hirokawa et al., 1992). 
There are also complementary strategies from other ligaments and musculotendon units, 
for example, the MCL and posteromedial capsule complement the ACL deficient knee 
secondarily by controlling anterior translation on the medial side of the joint. These 
complementary strategies are a reason why some ACL deficient patients are able to walk 
with normal gait patterns. However, some patients do not have this complementary 
function either because the ligament is completely destroyed or they have lost other 
complementary mechanisms. Therefore, ACL deficient patients can be divided into two 
groups: the copers and the non-copers. The copers are able to return to pre-injury activity 
without surgical intervention and non-copers require surgery to achieve the same outcome.  
There are different coping strategies exist among the copers: quadriceps avoidance or 
hamstring facilitation. In quadriceps avoidance, the patients avoid contracting the 
quadriceps to reduce the amount of knee flexion moment and to limit ATT. These 
modified processes occur especially during weight acceptance (less 40° of knee flexion and 
20-40% of stance phase) and midstance (full knee extension, 40-60% of stance phase) 
(Andriacchi, 1990; Berchuck et al., 1990). A partial ACL tear can lead to a complete tear 
depending on the amount of the tear, a subtle change in anterior translation and the 
occurrence of re-injury with giving-way. Besides, ACL injury can lead to meniscal or 
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chondral injury as well as osteoarthritis (Georgoulis et al., 2003). Where ‘quadriceps 
avoidance’ does not occur an alternative coping mechanism comes into play. ACL 
deficient copers have a functional adaptation in which the knee is flexed more which then 
positions the hamstrings to prevent abnormal anterior translation and internal or external 
rotation of the tibia through contraction in this flexed position (Beard et al., 1996).  
2.4 Treatment of ACL Injury  
The initial course of treatment of ACL injury includes rest, anti-inflammatory measures 
and activity modification. After the swelling resolves and normal range of motion and 
strength is achieved, a clinical test will be conducted as described previously, including the 
Lachman test (Logan et al., 2004b) and pivot shift test (Matsumoto, 1990). These clinical 
assessments will then define the type of treatment that the patient will undergo including 
only non-operative treatment as well as reconstruction surgery (Fitzgerald et al., 2000). 
Patients who have multiple injuries are normally required to undergo reconstruction 
surgery, where these other injuries can include other ligament tears, meniscal injuries or 
chondral legions. Conversely, patients with low-risk activity levels, isolated ACL injuries, 
and mild pathologic laxity may be successfully treated without surgery. Each patient will 
be evaluated separately, because of the complexity of the functional deficit and condition 
of other tissues. 
If a non-operative approach is chosen, the main treatment focus is to maintain the strength, 
balance, and range of motion in order to avoid further injury. During this treatment, many 
patients choose to use a sports brace and limit their participation in activities that require a 
lot of pivoting, cutting or jumping. The non-operative practice consists of several activities 
to improve functional of the knee.  
Some ACL injuries involve on a partial ligament tear and these are primarily treated non-
operatively, because the remaining ACL can provide a near-intact function. However, as 
with secondary restraints, there is a risk that the remaining ACL might further tear after 
certain types of activity introducing additional injuries to other structures of the joint. In 
the literature it has been shown that a one quarter tear does not progress to full tear, in a 
half tear 50% of the patients progress to a full tear and 86% of a three quarter tear progress 
to a full tear (Noyes et al., 1989). Copers should not progress to a full tear. However, the 
decision to undergo surgery cannot be based solely on the proportion of ligament that is 
intact.  
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2.5 Reconstruction Surgery 
Anterior cruciate ligament reconstruction (ACLR) surgery is a commonly performed 
procedure, particularly in athletes who want to return to competitive sport following an 
ACL injury. The decision to reconstruct is based on the clinical assessment, including the 
clinical tests described previously, the condition of the ACL as possibly quantified through 
medical imaging and the state of the other knee joint structures. Giving way as assessed by 
the pivot shift is a strong indication for reconstruction surgery as this is correlated with 
progression to osteoarthritis, a severe ACL tear, and other ligament injuries (Frank et al., 
1997).  
There is a variety of grafts used for reconstruction surgery, including allografts and 
autografts. The most commonly used grafts are autografts, in particular the patellar tendon 
bone to bone graft and a hamstrings graft (quadruple semitendinosus-gracilis tendon graft) 
(Brand et al., 2000). Both of the grafts have their strengths and weaknesses, with, for 
example, some papers showing residual ATT under complex loading (Woo et al., 2002). 
The surgical positioning is also important, for example, if the surgery places the graft too 
close to the central axis of the tibia and femur it is inadequate in resisting rotatory loads 
(Kanamori et al., 2000; Woo et al., 2002; Yagi M, 2002). Therefore, more laterally placed 
grafts have been advocated in some instances (Kanamori et al., 2000; Woo et al., 2002). 
Other techniques have included using a graft with multiple insertion points at both the tibia 
and femur to replicate the function of the separate bundles. These are termed, variously, 
double-bundle, or anatomic reconstructions (van Eck et al., 2010) (Kondo et al., 2008). 
Double bundle reconstruction replicated the native ACL anatomy by reconstruction the 2 
main functional bundles, the AMB, taut through full range of knee motion, and the PLB, 
taut mainly toward extension. The different behaviour of the 2 bundles should affect knee 
kinematics, and the AMB, which is closer to the line of knee axial rotation, controls mainly 
anterior laxity while the PLB, which is more divergent to the axis, controls rotation. The 
latter should also be involved in controlling the pivot-shift phenomenon, which is a 
combination of abnormal rotation and translation (Aglietti et al., 2009; Yagi et al., 2007; 
Zantop et al., 2007). Even though there is evidence that the double bundle reconstruction is 
superior to single bundle reconstruction, it is difficult to compare between single and 
double graft because they are not necessarily have a same procedure (van Eck et al., 2010).  
Despite the success of the ACL reconstruction, the current surgical treatment of ACL 
injury is costly, with variable outcomes (Hewett et al., 2013) and is associated with high 
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risk of post-traumatic osteoarthritis within two decades of injury (Murray et al., 2012). 
While few athletes are able to resume sports at the same level without surgery, the surgical 
reconstruction is also not always successful at returning patients to their pre-injury activity 
level. Furthermore, those athletes who successfully return to activity are at high risk of a 
second knee injury with notably less favourable outcomes. 
There is a lack of evidence that the outcomes of surgical treatment are better than those of 
nonsurgical treatment with respect to knee function, sports participation, or the early onset 
of knee osteoarthritis (Grindem et al., 2014). A systematic review recently reported fear of 
re-injury to be a more dominant reason for not returning to sport after ACL reconstruction 
than problems with the reconstructed knee (Ardern et al., 2011). Even though 44% of ACL 
reconstructed patients have been reported to return to sport (Ardern et al., 2011), and 24% 
of young people (10-25 years old) who had ACL reconstruction had a second ACL injury 
(Paterno et al., 2010). 
Reconstruction of the ACL with synthetic material, whether for total, permanent 
replacement, a scaffold for ingrowth of host tissue, or a stent to protect an allograft or 
autograft as it heals, has not proven to be satisfactory for treatment of a torn ACL 
(Beynnon et al., 2005). However, bio-enhanced repair using a collagen-based scaffold and 
autologous blood has shown a significant decrease in risk of post-traumatic osteoarthritis, 
which makes it the first and so far only possible ACL injury treatment with the potential to 
lower the risk of osteoarthritis after an ACL injury (Kiapour et al., 2014). However, this 
method is still new and is not used clinically. 
Similar to the ACL deficient knee, the ACL reconstructed knee required rehabilitation 
activities following surgery. It is interesting to know that hamstring exercises are not 
detrimental to ACL repairs or reconstruction and can be included early in the rehabilitation 
program after ACL surgery as these do not load the joint in ATT. However, the hamstrings 
are not capable of masking the potentially harmful effects of simultaneous quadriceps 
contraction on freshly repaired or reconstructed ACLs unless the knee flexion angle 
exceeds 30° (Renstrom et al., 1986). As knee stability is related to muscle strength, it is 
interesting to know if any contraction of knee muscle of the ACL deficient patient is able 
to treat these ACL patients to restore knee stability by using electrical stimulation without 
undergo any surgery. 
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2.6 Functional Electrical Stimulation (FES) 
FES has been used in the clinical arena to strengthen weak muscles by applying low level 
electrical currents (Peckham, 1987). FES has been widely used clinically to contract the 
paralyzed or paretic muscles of upper motor neuron lesions such as spinal cord injury 
(SCI) patients (Lynch et al., 2008), cerebral palsy (Carmick, 1997), Parkinson’s and 
multiple sclerosis. Neuromuscular electrical stimulation (NMES) assists in strengthening 
weak muscle in orthopaedic conditions. Both FES and NMES have the same function in 
that they assist in contracting the weak muscles; the difference is that FES contracts muscle 
to assist in any functional activities (eg walking) while NMES contracts muscle during a 
static position (eg sitting at a certain knee flexion angle). NMES has been used to restore 
quadriceps strength of the ACL deficient patient following surgery. This is because the 
quadriceps muscles are often affected by arthrogenic muscle inhibition after ACL 
reconstruction, which limits volitional contraction. NMES directly recruits the motor 
neurons to produce better quadriceps strength gains than voluntary exercise alone. 
Functional outcomes are improved with increased strength gains of the quadriceps 
(Palmieri-Smith et al., 2008).  
Based on previous studies, ACL deficient and ACL reconstructed knees may still have 
residual instability in ATT and tibial internal rotation. The combination of the conforming 
surface of tibia and the muscles of the knee are able to reduce these knee instabilities. The 
important thing is to find the right muscle to contract which is able to assist in stabilising 
the knee movements of the patients. The stimulation of hamstrings using a functional knee 
brace with FES has been shown to assist a patient in walking (Solomonow, 2006). The 
literature has also proposed using FES to contract the hamstrings to reduce ATT (Chen et 
al., 2013), however, this was only tested in healthy subject. There is no other study in the 
open literature that explores the contraction of the hamstrings with FES in order to restore 
the knee stability in ACLD and ACLR patients. Stimulating the hamstrings, especially the 
biceps femoris long head (BFLH) with its insertion on the fibular head is a candidate to 
target to apply a posterior pull and external rotation to the tibia.   
Based on a review by Maffiuletti (2010), there are two aspects for physiological 
considerations with the use of NMES which are: the differences in motor unit recruitment 
pattern between NMES and voluntary contractions, and the involvement of the nervous 
system during peripheral NMES. These physiological aspects also apply to FES. 
31 
 
The first physiological consideration is the differences in motor unit recruitment pattern 
between NMES and voluntary contractions. NMES stimulates synchronous recruitment 
which stimulates all muscle units at the same time. In contrast, the nervous system 
stimulates muscles in a sequential manner. The recruitment of motor units during NMES is 
without obvious sequencing related to unit types which is referred as the “disorderly” 
recruitment (Gregory et al., 2005) and thus, NMES (20-40Hz) needs a higher FES 
frequency than the nervous system (6-8Hz) to stimulate muscle (Lynch et al., 2008). 
NMES also tends to recruit fast twitch muscle fibres over slow twitch muscle fibres, 
because fast twitch muscle fibres have larger diameter axon that can be recruited before the 
smaller slow fast twitch muscle fibres. The large-diameter axons, mostly located in 
superficial muscles such as vastus medialis, are more easily excited by electrical stimuli 
because they have the lowest threshold of activation (Maffiuletti, 2010). Increasing the 
NMES current intensity or prolonging the duration of NMES in a rehabilitation could 
depolarise the new fibres located at a greater, which is deeper, distance from the electrode, 
while the closer, superficial, ones maintain their contractile activity. Both these effects of 
synchronous recruitment and preferential recruitment of fast twitch muscle fibres 
contribute to muscle fatigue. It is known that muscle fatigue increases with pulse 
frequency. Lower amplitude stimulation with longer pulse durations reduces fatigue. 
Muscle fatigue can also be reduced through training; FES training can increase muscle 
volume and increase muscle strength. Higher frequency with intermittent FES electrical 
pulses contributes to less muscle fatigue compared to low frequency intermittent FES 
electrical pulses (Matsunaga et al., 1999). Pulse frequency, pulse amplitude and pulse 
duration (Ferrarin et al., 2000) are all parameters that can be tuned for the orthopaedic 
patient, as appropriate for their physical condition, such as injury, recent surgery or 
impaired activation in performing high-intensity voluntary contractions. Table 2.1 shows 
the differences in motor unit recruitment during voluntary and NMES contractions 
(Maffiuletti, 2010). 
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Table 2.1 Motor unit recruitment during voluntary contraction and NMES contraction (from Maffiuletti, 
2010) 
Characteristics Voluntary contraction NMES contraction 
Temporal Asynchronous Synchronous 
Spatial Dispersed Superficial 
 Rotation is possible Spatially fixed 
 Quasi-complete (even 
at the the maximum) 
Largely incomplete (even at the 
maximum) 
Orderly Selective (slow to fast) No, nonselective/random/disorderly 
(slow and fast) 
Consequence Partially fatiguing Extremely fatiguing 
 
The second physiological consideration is the involvement of the nervous system during 
NMES which contributes to the clinical gains observed during motor recovery. NMES 
increases cortical activity (Smith et al., 2003) and NMES increases spinal motoneuron 
recruitment (Collins, 2007). High training intensities would mainly promote supraspinal 
adaptations which train populations of slow and fast muscle fibers. Wide pulse (1 ms) high 
frequency (50-100Hz) (Collins, 2007) NMES would likely result in changes at the spinal 
level which train the slow fibers. However, these suggestions in the literature need further 
investigation by controlled studies in both healthy and patient populations (Maffiuletti, 
2010).  
The goal of ACL reconstruction surgery is to improve anterior translational and internal 
rotation knee stability but even after ACL reconstruction, sagittal translation may remain 
elevated. There are no specific muscle-related criteria that have been shown to correlate 
significantly with a successful return to sports activities after ACL reconstruction other 
than, simply, muscle strength (Micheo et al., 2010). However, it is recognised that  
functional stability and good muscle function are important aspects that need to be 
addressed after reconstruction surgery before return to sports activities (Kvist, 2004). This 
can be done with NMES. There is  some evidence of a beneficial effect of NMES together 
with conventional rehabilitation exercises (volitional training) in improving muscle 
strength and function two months after ACL reconstruction surgery (Imoto et al., 2011). 
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NMES has been used clinically in the early postoperative surgery phase (Noyes et al., 
2006). The activities involved mostly focus on strengthening the quadriceps as these are 
affected by arthrogenic muscle inhibition. Six months after reconstruction surgery, the 
quadriceps have a muscle deficit of 19-44% and hamstring having muscle deficit of less 
than a 10% (Kvist, 2004). Training with NMES while the patient is in a sitting position 
with a steadily held knee flexion angle has been used from 3 to 14 weeks postoperatively 
(Kim et al., 2010). Various researchers recommend different time periods for the use of 
NMES, citing, for example, the significant muscle weakening in the first six weeks as 
evidence for the use of NMES in that period (Imoto et al., 2011). Treatment times and 
durations vary from 30 minutes to 10 hours per day or by, for example, performing 15 
repetitions over a daily or every other day (Snyder-Mackler et al., 1994; Snyder-Mackler et 
al., 1995; Snyder-Mackler et al., 1991). These different NMES parameters may have an 
impact on the clinical outcomes of treatment and the lack of consistency in the literature 
make it difficult for clinicians to select appropriate parameters (Kim et al., 2010). There is 
evidence that treatment with NMES in combination with conventional rehabilitation 
exercises results in greater quadriceps strength compared to doing volitional training alone 
(Bax et al., 2005; Palmieri-Smith et al., 2008), however, others suggest that NMES 
provides no benefit, perhaps due to the work effort and overall training intensity (Kim et 
al., 2010) and wide variety of parameters utilised across trials (Risberg et al., 2004). Also, 
the different injury/surgical condition of each individual will affect the treatment outcome 
(Maffiuletti, 2010).  
Studies have used NMES with extremely different frequencies of between 35 to 70Hz 
(Imoto et al., 2011; Kim et al., 2010; Paillard, 2008). Higher frequencies (above 50Hz ) 
have been shown to deliver at sensory intensity (DeSantana et al., 2008), while lower 
frequencies (lower 10Hz) have been shown to deliver at motor intensity (DeSantana et al., 
2008). Most studies used NMES with a frequency of 40 Hz which is claimed suitable for 
eliciting reflectors. The suitable pulse duration should be around 200 to 350 microseconds 
(Imoto et al., 2011). The stimulus can be made more comfortable for the patient by slowing 
the rising and falling edges of the stimulation with a ramp time of 1-2 seconds being 
suitable but some users with severe spasticity require a ramp time of 6s or above 
(DeSantana et al., 2008). This demonstrates that stimulation with 40Hz, 200 to 350 
microseconds with 1-2 seconds ramp times of rising and falling edges are suitable to 
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provide sufficient muscle contractions. Therefore, in this thesis the stimulation parameters 
will be set according to these parameters.  
There are some drawbacks with the clinical approach described above. First, NMES is 
generally delivered at a fixed joint angle where the effects of NMES are considered to be 
poorly related to functional activities of daily living or to sporting activities that occur over 
a range of knee joint flexion angles. Second, NMES is mostly used during the early post-
operative phase, where potential benefits even 6 months after surgery, at which point 
rehabilitation post ligament reconstruction surgery is increased, could help to improve the 
thigh musculature before return to sports activities. In particular, the hamstrings muscles 
have less deficit after surgery compared to quadriceps muscles, and so, based on their 
physiological line of action and strength, stimulating these during walking could further 
improve knee instability by reducing the ATT. 
There is robust evidence of a beneficial effect of NMES for ACL rehabilitation. Using 
NMES has shown that the quality of quadriceps activation is greater compared to 
rehabilitation treatment without NMES treatment. However, there are no significant 
differences in endurance, maximum voluntary isometric torque, function or quality of life 
(Monaghan et al., 2010). Overall, while NMES stimulation may potentially strengthen 
quadriceps muscles, this does not appear to be a requirement for successful ACL 
reconstruction rehabilitation (Wright et al., 2008). Treatment with FES during activity 
could potentially provide better knee stability and performance for ACL deficient and ACL 
reconstructed patients.  
The interplay between knee stabilisation and musculoskeletal system restraint with FES 
stimulating BFLH is not known for ACL deficient and ACL reconstructed patients. 
Besides, the level of BFLH muscle activation activated with FES that can reduce the knee 
instability needs to be investigate. Quantifying this level of activation can be achieved 
through the use of musculoskeletal modelling and so a new model needs to be developed to 
estimate BFLH muscle contraction with FES to then be used to analyse ACL deficient 
patients focussing on their knee joint stability in the plane of articulation, focusing on the 
key effects in rotation and translation.  
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2.7 Conclusion 
Knee stability is achieved by a good collaboration between the active and the passive knee 
stabilisers, which are the muscles and the ligaments. The injured ACL causes increased 
translation and rotational laxity on the lateral side of the tibia. The reconstructed ACL also 
suffers from residual rotational instability. Quadriceps strengthening can assist in 
addressing inhibition atrophy, but there is no work that has properly explored the potential 
of stimulating hamstrings using FES, especially BFLH, to reduce the knee instability of 
ACL deficient and as well as ACL reconstructed patients. In addition, the prospect of 
enhancing BFLH interactions at the knee may enable non-copers to become copers and 
potentially reduce the need for surgery. Knee injury is associated with adaptive changes in 
walking that can be detected using gait analysis. However, gait analysis on its own does 
not fully characterise knee mechanics and since muscle forces cannot be measured directly, 
a lower limb musculoskeletal model is required to understand knee mechanics in gait. 
Current musculoskeletal models do not allow the imposition of muscle stimulation using 
FES and therefore a modification of such models is required to investigate the contraction 
of BFLH with FES and explore its ability to reduce knee instability of ACL deficient and 
ACL reconstructed knees.  
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CHAPTER 3 1 
Musculoskeletal Modelling to Investigate the Use of FES at the Knee 
This chapter introduces a modification of musculoskeletal modelling to enable the 
assessment of the ability of FES to stimulate muscles around the knee to change the local 
articular loading. The study is focused on biceps femoris long head (BFLH) of healthy 
subjects and the loading of interest is anterior shear force and internal tibial rotation torque.  
  
                                                            
1
Part of this chapter has been published as “Azmi NL, Ding Z, Xu R, Bull AMJ (2018) Activation of biceps 
femoris long head reduces tibiofemoral anterior shear force and tibial internal rotation torque in healthy 
subjects. PLoS ONE 13(1): e0190672. https://doi.org/10.1371/journal.pone.0190672” 
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3.1 Introduction 
As described full in Chapter 2, healthy loading of the tibiofemoral joint of the knee during 
activities of daily living including gait involves significant tibial anterior shear and tibial 
internal rotation torque (Andersen et al., 1997), in particular during the stance phase of gait 
(Escamilla et al., 2012). The anterior cruciate ligament (ACL) is the primary restraint to 
anterior shear and a major secondary restraint to internal tibial rotation (Noyes et al., 
1983b). Therefore, ACL deficiency through sports trauma results in anterior tibial 
translation instability and tibial internal rotational instability of the knee (Duthon et al., 
2006).  
Knee movement is a function of external forces and of muscle forces (Shelburne et al., 
2005). In ACL-deficiency, knee joint stability is provided through the action of concavity 
compression of the tibiofemoral articulation on the medial side, where the compressive 
forces push together the concave surfaces of the joints (Amis et al., 2005). However, this 
stability mechanism is not present at the lateral knee compartment as the lateral tibial 
plateau is convex, which, combined with the convex femoral condyle, results in an 
unstable and more mobile compartment. As a result, during normal knee joint loading with 
a tibial rotational torque, the rotational axis of the knee moves medially creating an 
excessive translation of the lateral compartment (Amis et al., 2005; Bull et al., 1999; Gao 
et al., 2010; Shimokochi et al., 2008). These excessive movements then cause secondary 
conditions including damage to the other passive restraints to these motions, such as 
cartilage, menisci, and the collateral ligaments (Noyes et al., 1980; Noyes et al., 1983a; 
Shao et al., 2011). ACL deficiency is implicated with an increase in the rate of 
osteoarthritis (Lohmander et al., 2007; Solomonow, 2006) and limits athletes in their 
activity (Catalfamo et al., 2010).  
As described in Chapter 2, there is a subset of ACL deficient patients who are able to 
return to pre-injury activity without surgical intervention; these are termed copers. Non-
copers require surgery to achieve the same outcome. A third group is that of non-copers 
who undergo ACL reconstruction surgery, where there is a residual internal rotation 
instability.   
Coping is achieved through avoiding muscular contraction that produces an anterior shear 
force through, for example, avoiding full contraction of the quadriceps especially during 
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the early stance phase and when the knee is at full extension (Escamilla et al., 2012). An 
alternative coping mechanism counteracts quadriceps contraction through co-contraction of 
the hamstrings (Rudolph et al., 2001; Sinkjaer et al., 1991) and through the adaptation of 
muscle firing (Andriacchi et al., 2005). The underpinning hypothesis of this work is to 
adapt muscle firing through functional electrical stimulation (FES) in order to restore 
normal ATT at the lateral compartment of the knee by causing specific muscles to contract.  
The main muscles involved in the movement of the knee are the quadriceps, gastrocnemius 
and hamstrings. Of these, the hamstrings afford the most potential to reduce anterior tibial 
shear force and thus restore ATT to normal (Liu et al., 2000; Markolf et al., 2004; 
Shelburne et al., 2005) as they are anatomically located to apply a posterior pull to the tibia 
(Yanagawa et al., 2002).  Biceps femoris long head (BFLH) is the best candidate for 
selective activation in order to resist the peaks of anterior shear force and internal rotation 
moments during the stance phase of gait (Shelburne et al., 2005). It has been shown in a 
modelling study that activation of biceps femoris is able to decrease the anterior tibial 
shear force when knee flexion is less than 40° (Biscarini et al., 2013). Additionally, 
because BFLH attaches to the fibular head on the lateral aspect of the knee, it is expected 
that it will also be able to resist the large internal rotation moment and hence the large 
pathological motion of the lateral compartment in ACL deficiency (Amis et al., 2005; Gao 
et al., 2010). Thus, it is hypothesized that activation of BFLH is able to restore knee 
stability in non-copers to allow them to become copers.  
The aim of this chapter is to: 
1. modify a musculoskeletal model to investigate the effect of FES of the BFLH on 
internal rotation torque and anterior tibial shear force at the knee; 
2. explore the optimal level of muscle activation to reduce internal rotation torque and 
anterior tibial shear force; and 
3. test the use of FES on BFLH in healthy control subjects. 
 
3.2 Materials and Methods 
Physical Experiments 
An Imperial College Research Ethics application was submitted previously and ethics 
approval was granted in 2014. The full application is shown in Appendix A. Written 
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informed consent was obtained from all participants. In this pilot study, twelve healthy 
subjects (5 male, 7 female; height 1.67 ± 0.09 m; mass 66.74 ± 16.75 kg; age 26.08 ± 2.39 
years) underwent level walking without and with FES (Table 3.1).  
Table 3.1 Anthropometric data 
Subject Gender Height (m) Mass (kg) Age (year) 
1 Male 1.61 61.00 25 
2 Female 1.68 54.10 26 
3 Female 1.60 48.90 28 
4 Female 1.62 54.20 25 
5 Female 1.59 54.40 30 
6 Male 1.63 62.70 28 
7 Male 1.87 93.00 27 
8 Male 1.77 85.50 26 
9 Male 1.67 88.30 23 
10 Female 1.74 88.50 27 
11 Female 1.58 54.50 21 
12 Female 1.71 55.80 27 
Mean 1.67 66.74 26.08 
SD 0.09 16.75 2.39 
 
The FES electrodes (Odstock 2 Channel Stimulator, Odstock Medical Ltd., UK) were 
placed over the right BFLH with one electrode at the bottom of the BFLH and one at the 
centre, with a distance of two hand widths between them. The frequency of the stimulator 
was set to the manufacturer recommended level of 40 Hz and simulation current was 
initially set to a minimum value of 40 mA. The intensity was then adjusted to the 
maximum level that the subject was able to comfortably withstand. The intensity level 
stimulation pulse width potentially ranged from level 0 to 9 (0 to 350µs), yet in this case 
pulse durations were varied between level 4 and 8 on a subject-specific basis; this is within 
the suitable pulse durations for NMES as described in Chapter 2 (Imoto et al., 2011) 
(Figure 3.1).  
 
Figure 3.1 Stimulation pulse width intensity level 
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The stance phase that was analysed in this study started from the point at which the right 
heel stepped on the force plate (initial contact).  All subjects underwent a practice session 
using the FES before the trials were recorded. This practice session ensured that the subject 
adapted to the stimulation while their right foot stepped on the force plate. The FES 
stimulation current was set up to start from one second of ramp up, followed by four 
seconds of maximum current and then end up with one second of ramp down (Figure 3.2 
and Figure 3.3). The stimulator was manually started by the subject pressing the hand 
switch button, and timed so that the stimulation current was at its maximum value from 
when the right foot stepped on the force plate, through heel strike, until toe off. As there 
were multiple stance phases before the right leg stepped on the force plate, 4 seconds of 
stimulation ensured that the peak of stimulation occurred throughout the stance phase 
whilst on the force plate. The subject was advised to press the hand switch button (Figure 
3.4) and wait for 1 second before starting to walk from one walking end of the walkway, 
which is 2.39 metres long, to the other (Figure 3.5). The ramp time of 1second set at the 
beginning and end of the stimulation is to provide comfort to the patient throughout the 
stimulation applied to the muscle (DeSantana et al., 2008).  
 
 
Figure 3.2 The FES stimulation setting 
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Figure 3.3 Schematic of stimulation output normalised to maximum stimulation level 
 
Figure 3.4 The FES device and the switch 
The subjects walked for six trials for normal gait and six for FES gait, of which a random 
selection of three trials each were used for data analysis. All subjects started with normal 
gait, following by FES trials. 
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Figure 3.5 Lab set-up 
Walking speed, tibial internal rotation torque, and anterior shear force were the gait 
measures of interest, where speed is included, because muscle activity changes are 
influenced by speed of walking (Arnold et al., 2013). Ground reaction forces (GRF) were 
recorded at 1000 Hz from a force plate (Kistler Type 9286BA, Kistler Instrument AG, 
Winterthur, Switzerland). A ten-camera motion analysis system (Vicon Motion Systems 
Ltd, Oxford, UK) recorded the motion of the right lower limb at 200 Hz; eighteen retro-
reflective markers were attached to the foot, thigh and pelvis with an additional two 
clusters of three markers attached to the shank and thigh (Duffell et al., 2014) (Figure 3.6) 
(Table 3.2). 
Walking path 
Force plate 
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Table 3.2 Marker positions 
Marker  Location  
RASIS  Right anterior superior iliac spine  
LASIS  Left anterior superior iliac spine  
RPSIS  Right posterior superior iliac spine  
LPSIS  Left posterior superior iliac spine  
FLE  Lateral femoral epicondyle  
FME  Medial femoral epicondyle  
T1, T2, T3  Additional markers placed on the thigh 
segment  
FAM  Apex of the lateral malleolus  
TAM  Apex of the medial malleolus  
S1, S2, S3  Additional markers placed on the shank 
segment  
FCC  Calcaneus  
FMT  Tuberosity of the fifth metatarsal  
FM2  Head of the second metatarsal  
TF  Additional marker placed on the foot  
 
  
Figure 3.6 Optical motion tracking markers and FES electrode positioning 
Lower limb musculoskeletal model 
Musculoskeletal modelling allows the quantification of internal forces such as muscle and 
joint forces with gait data input. There is one commercial musculoskeletal modelling 
software available, Anybody  (Damsgaard et al., 2006). This software has an accurate 
lower limb model which has been validated for various tasks with implementation of 
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different muscle recruitment methods and a focus on the knee (Marra et al., 2015). 
However, there is no clear method to modify the internal algorithms to allow the modelling 
of FES. In addition, there are two open source musculoskeletal modelling software 
packages available, OpenSim (Delp et al., 2007) and Freebody (Cleather et al., 2015; Ding 
et al., 2016). Of these, Freebody is the most flexible in that all the code is written in C++ 
and Matlab, allowing full modification of the code. In addition, as this study is focusing on 
ACL surgery at the knee, it is important to use a model that allows physiological and 
pathological joint translations at the knee to be modelled. OpenSim assumes a fixed centre 
of rotation and so is unable to model these translations.  
Therefore, the open source musculoskeletal modelling software, Freebody V2.1 (Cleather 
et al., 2015; Ding et al., 2016), was used in this study. The segment-based lower limb 
model consists of the foot, shank, thigh, pelvis and patella segments. The patella is 
assumed to be massless in the model. Its position and orientation were determined based 
on the knee flexion angles and the length of patella ligament.  
The model inputs are the kinematics data from the retro reflective markers and the kinetic 
data from the force plate, as can be obtained from any standard gait lab. The model 
calculates the intersegmental forces and torque at the proximal end of each segment 
(Dumas et al., 2004). The internal rotation torque was obtained from the inverse dynamics 
method. Each subject’s anatomical geometry was created by linear scaling of an MRI-
based anatomical dataset (Ding et al., 2016). The definition of the parameters of the linear 
scaling law is based on a study by Nolte et al., (2016): the pelvis width was calculated as 
the distance between the right and left anterior iliac spine landmarks; the segment lengths 
were defined as the distance between the hip joint centre and the midpoint between the 
lateral and medial femoral epicondyles, the shank segment from the femoral epicondyle 
midpoint and the midpoint between the tibial and fibula malleoli, and the foot segment as 
from the mid malleoli and distal end of the second metatarsal (Nolte et al., 2016). 
The dataset consists of 163 muscle elements representing 38 lower limb muscles. The 
muscle attachment sites, joint centres of rotation and tibiofemoral contact points were 
manually digitized from the MR imaging of a male subject (1.83 m, 96 kg, 44 years) (Ding 
et al., 2016). The model quantifies the muscular and joint reaction forces experienced by 
the lower limb during the recorded movement through minimisation of a cost function 
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(Crowninshield et al., 1981) (Equation 3.1). This optimisation is termed standard 
optimisation throughout this thesis: 
𝑀𝑖𝑛 ∑ (
𝑓𝑖
𝑓𝑚𝑎𝑥𝑖
)
3163
𝑖=1
                                                                                                          Equation 3.1 
where fi is the muscle force of muscle element i ( i =1,…,163) and fmaxi  is the maximal 
muscle force of muscle element i, which is determined by multiplying published 
physiological cross-sectional areas of muscle element i by an assumed maximum muscle 
stress of 31.39 N/cm
2
 (Yamaguchi, 2001), constrained by the equations of motion of the 
whole lower limb (Equation 3.2): 
[
𝑆𝑖
𝑀𝑖
] = [
𝑚𝑖𝐸3×3 03×3
𝑚𝑖𝑐𝑖 𝐼𝑖
] [
𝑎𝑖 − 𝑔
?̈?𝑖 
] + [
03×1
?̇?𝑖 × 𝐼𝑖?̇?𝑖
] [
𝐸3×3 03×3
𝑑𝑖 𝐸3×3
] [
𝑆𝑖−1
𝑀𝑖−1
]           Equation 3.2 
where 𝑖 is the segment number or joint number (numbering from distal to proximal), 𝑆𝑖 the 
proximal intersegmental forces, 𝑆𝑖−1 the distal inter-segmental forces, 𝑀𝑖 the proximal 
intersegmental moments (notional joint moments), 𝑀𝑖−1 the distal intersegmental moments 
(notional joint moments), 𝐼𝑖 the inertia tensor, ?̈?𝑖  the angular acceleration about center of 
motion (COM), ?̇?𝑖 the angular velocity about center of motion (COM), ai the linear 
acceleration of COM, 𝑚𝑖 the segment mass, E3X3 the identity matrix, ci the vector from the 
proximal joint to the segment COM and di  is the vector from the proximal to the distal 
joint. 
In order to quantify the effect of higher muscle activation of BFLH produced by the FES at 
the knee, a revised optimisation method is proposed (Equation 3.3): 
𝑚𝑖𝑛 ∑ (
𝑓𝑖
𝑓𝑚𝑎𝑥𝑖
)
3162
𝑖=1
                                                                                                           Equation 3.3  
where fi is the muscle force of muscle element i (i=1,…,162) and fmaxi is the maximal 
muscle force of muscle element i. 
In the revised optimisation method, the muscle element is reduced to 162 because the 
muscle force of BFLH, f26 is set as a constant value during the stance phase to replicate the 
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physical stimulation of the muscle by FES. This value is set at a muscle activation, c, times 
the maximum force of BFLH, 𝑓𝐵𝐹𝐿𝐻𝑚𝑎𝑥 , where  f26 = 𝑐 × 𝑓𝐵𝐹𝐿𝐻𝑚𝑎𝑥. As the attachment sites 
of BFLH are on the shank and thigh segments, the equations of motion of the shank and 
thigh segments (Equation 3.2) were modified by the inclusion of an additional term to give 
(Equation 3.4): 
[
𝑆𝑖
𝑀𝑖
] = [
𝑚𝑖𝐸3×3 03×3
𝑚𝑖𝑐𝑖 𝐼𝑖
] [
𝑎𝑖 − 𝑔
?̈?𝑖
] + [
03×1
?̇?𝑖 × 𝐼𝑖?̇?𝑖
] + [
𝐸3×3 03×3
𝑑𝑖 𝐸3×3
] [
𝑆𝑖−1
𝑀𝑖−1
]                                 
− [
(𝑐 × 𝑓𝐵𝐹𝐿𝐻𝑚𝑎𝑥) ∙ 𝑛𝐵𝐹𝐿𝐻 
(𝑐 × 𝑓𝐵𝐹𝐿𝐻𝑚𝑎𝑥) ∙ (𝑟𝐵𝐹𝐿𝐻  × 𝑛𝐵𝐹𝐿𝐻)
]                                        Equation 3.4 
 
where 𝑆𝑖 the revised proximal intersegmental forces, 𝑆𝑖−1 the revised distal inter-segmental 
forces, 𝑀𝑖 the revised proximal intersegmental moments (notional joint moments), 𝑀𝑖−1 
the revised distal intersegmental moments (notional joint moments), c is a constant, 
𝑓𝐵𝐹𝐿𝐻𝑚𝑎𝑥 the maximum force of BFLH, 𝑛𝐵𝐹𝐿𝐻   the line of action of BFLH and 𝑟𝐵𝐹𝐿𝐻 the 
moment arm of BFLH. In this study, 𝑐 was increased in increments of 0.05 until the peak 
anterior tibial shear was reduced to zero, where 𝑐 is a value between 0 and 1, to make sure 
that the BFLH force does not exceed its maximum activation value. The increment of 
BFLH activation theoretically causes a reduction in tibial internal torque, which was 
calculated as the product of the increment of BFLH muscle force and its moment arm at 
the time frame at which peak anterior tibial shear was occurred.  
 
Data Analysis 
The walking speed (as calculated from the stance phase only), knee joint torque, anterior 
shear force, and knee contact force were averaged over three trials and presented as a mean 
value. Knee joint torque and knee contact force were presented in the tibial coordinate 
frame. The stance phase was expressed in a 0-100% duration with a step interval of 1% 
using cubic spline data interpolation. To test the hypothesis that the peak of the tibial 
internal rotation torque and the anterior shear force were reduced by applying the FES over 
the BFLH, the differences between normal gait and FES gait were compared using a one-
tail paired-samples t-test with an α level of 0.05. All data processing and analysis was 
conducted in MATLAB (The Mathworks Inc., Natick, MA). 
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3.3 Results 
FES gait mean walking speed (as calculated from the stance phase only) 0.25±0.04 m/s 
was lower than that during normal gait (0.27±0.03 m/s; p=0.036).  The peak value of the 
tibial internal rotation torque across all subjects was 0.0012±0.0010 Nm/BW during 
normal gait. It was reduced by 63% to 0.0005±0.0004 Nm/BW (p=0.032) when BFLH was 
stimulated by FES (Table 3.3) (Figure 3.7).  
Table 3.3 Peak tibial internal rotation torque (Nm/BW) during normal and FES gait 
Peak internal rotation torque (Nm/BW) 
Subject Normal gait  FES gait 
1 0.0006 0.0006 
2 0.0003 0.0004 
3 0.0009 0.0001 
4 0.0037 -0.0001 
5 0.0007 0.0007 
6 0.0028 -0.0004 
7 0.0007 0.0009 
8 0.0010 0.0004 
9 0.0010 0.0008 
10 0.0015 0.0009 
11 0.0010 0.0007 
12 0.0007 0.0005 
Mean 0.0012 0.0005 
SD 0.0010 0.0004 
 
  
Figure 3.7 Peak tibial internal torque (Nm/BW) across twelve subjects during normal and FES gait 
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Figure 3.8-3.19 shows the tibial internal rotation torque of all subjects during normal and 
FES gait.  
 
Figure 3.8 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 1 during normal and FES gait  
 
Figure 3.9 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 2 during normal and FES gait 
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Figure 3.10 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 3 during normal and FES gait 
 
Figure 3.11 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 4 during normal and FES gait 
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Figure 3.12 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 5 during normal and FES gait 
 
Figure 3.13  Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 6 during normal and FES gait 
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Figure 3.14 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 7 during normal and FES gait 
 
Figure 3.15 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 8 during normal and FES gait 
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Figure 3.16 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 9 during normal and FES gait 
 
Figure 3.17 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 10 during normal and FES gait 
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Figure 3.18 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 11 during normal and FES gait  
 
Figure 3.19 Tibial internal rotation torque (Nm/BW) (mean ± SD) of subject 12 during normal and FES gait 
The first peak of adduction torque and flexion torque were not significantly different 
during FES gait compared to normal gait (p=0.3457 and p=0.2623, respectively; Table 3.4, 
Figure 3.20). 
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Table 3.4 Peak tibial adduction torque (Nm/BW) and peak tibial flexion torque (Nm/BW) during normal and 
FES gait 
Subjects Peak adduction torque (Nm/BW) Peak flexion torque (Nm/BW) 
Normal gait FES gait Normal gait FES gait 
1 0.0361 0.0344 0.0464 0.0397 
2 0.0427 0.0411 0.0589 0.0516 
3 0.0326 0.0338 0.0643 0.0514 
4 0.0232 0.0298 0.1193 0.0952 
5 0.0480 0.0466 0.0755 0.0933 
6 0.0592 0.0546 0.0477 0.1804 
7 0.0446 0.0434 0.0300 0.0310 
8 0.0095 0.0122 0.0704 0.0594 
9 0.0152 0.0080 0.0352 0.0429 
10 0.0452 0.0440 0.0616 0.0571 
11 0.0401 0.0415 0.0477 0.0498 
12 0.0375 0.0394 0.0564 0.0543 
Mean 0.0361 0.0357 0.0594 0.0672 
SD 0.0142 0.0136 0.0232 0.0405 
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Figure 3.20 (a) Tibial adduction torque (Nm/BW) and (b) tibial flexion torque (Nm/BW) during normal and 
FES gait for all subjects (mean ± SD, n=12) 
 
In the standard optimisation method, the peak anterior shear force occurred at 18.8% 
(±6.0%) of stance phase with a mean value of 0.289 ± 0.077 BW. The muscle activation of 
BFLH at peak anterior shear was 0.015 ± 0.021 (Table 3.5).   
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Table 3.5 Peak anterior shear force (BW) and muscle activation 
Subject Peak anterior 
shear force 
during normal 
gait (BW) 
% stance 
phase 
BFLH muscle 
activation 
𝑐 Peak anterior 
shear force 
during FES gait 
(BW) (𝑐 =0.208) 
1 0.288 26.0 0.002 0.20 -0.030 
2 0.187 23.0 0.016 0.15 -0.330 
3 0.310 20.0 0.000 0.15 -0.140 
4 0.423 19.0 0.000 0.10 -0.620 
5 0.278 26.0 0.000 0.40 -0.498 
6 0.178 15.0 0.067 0.25 -0.272 
7 0.201 5.0 0.054 0.30 0.078 
8 0.265 16.0 0.013 0.20 -0.176 
9 0.275 23.0 0.016 0.20 -0.116 
10 0.420 15.0 0.000 0.20 -0.132 
11 0.348 23.0 0.001 0.20 -0.247 
12 0.297 15.0 0.013 0.15 -0.221 
Mean 0.289 18.8 0.015 0.208 -0.225 
SD 0.077 6.0 0.021 0.084 0.192 
 
Increasing BFLH activation incrementally resulted in an incremental reduction in the 
anterior shear force for all subjects (Figure 3.21-Figure 3.32). The activation of BFLH 
(expressed as 𝑐 value) required to reduce the peak anterior shear force to zero in the 
revised optimisation ranged from 0.15 to 0.40 with a mean 𝑐 value of 0.208±0.084 (Table 
3.5). Applying the mean value of 0.208 to all subjects, reduced the peak anterior shear 
force to below zero in 11/12 subjects and was 0.078 BW for the other subject (Table 3.5; 
Figure 3.33). At the time frame at which peak anterior shear force occurred, the reduction 
in tibial internal torque was calculated as the product of the increment of BFLH muscle 
force and its moment arm at that time frame. This level of muscle activation at 0.208 
caused a reduction of the internal rotational torque of 0.023±0.0167 Nm/BW (p<0.001) 
(Table 3.6).  
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Table 3.6 Difference mean peak internal rotational torque (Nm/BW) 
Subject Mean peak internal rotational torque  (Nm/BW) 
Normal gait FES gait Difference (FES gait 
– normal gait) 
1 0.0049 0.0376 0.0327 
2 0.0080 0.0294 0.0214 
3 0.0004 0.0302 0.0298 
4 0.0000 0.0216 0.0215 
5 0.0051 0.0660 0.0609 
6 0.0181 0.0605 0.0424 
7 0.0350 0.0333 -0.0017 
8 0.0100 0.0313 0.0213 
9 0.0044 0.0173 0.0129 
10 0.0025 0.0163 0.0138 
11 0.0487 0.0486 0.0000 
12 0.0205 0.0365 0.0160 
Mean 0.0131 0.0357 0.0226 
SD 0.0145 0.0150 0.0167 
 
 
Figure 3.21 Anterior shear force (BW) (mean ± SD) of subject 1 during normal and FES gait 
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Figure 3.22 Anterior shear force (BW) (mean ± SD) of subject 2 during normal and FES gait 
 
Figure 3.23 Anterior shear force (BW) (mean ± SD) of subject 3 during normal and FES gait 
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Figure 3.24 Anterior shear force (BW) (mean ± SD) of subject 4 during normal and FES gait 
 
Figure 3.25 Anterior shear force (BW) (mean ± SD) of subject 5 during normal and FES gait 
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Figure 3.26 Anterior shear force (BW) (mean ± SD) of subject 6 during normal and FES gait 
 
Figure 3.27 Anterior shear force (BW) (mean ± SD) of subject 7 during normal and FES gait 
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Figure 3.28 Anterior shear force (BW) (mean ± SD) of subject 8 during normal and FES gait 
 
Figure 3.29 Anterior shear force (BW) (mean ± SD) of subject 9 during normal and FES gait 
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Figure 3.30 Anterior shear force (BW) (mean ± SD) of subject 10 during normal and FES gait 
 
Figure 3.31 Anterior shear force (BW) (mean ± SD) of subject 11 during normal and FES gait 
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Figure 3.32 Anterior shear force (BW) (mean ± SD) of subject 12 during normal and FES gait 
 
Figure 3.33 Predicted peak anterior shear force across twelve subjects using standard and revised 
optimisation methods 
There was no significant difference for the first peak of medial knee compressive force 
(p=0.2373, Figure 3.34a). The first peak of lateral knee compressive force was increased 
by 276% (p<0.0001, Figure 3.34b) during FES gait compared to normal gait, resulting in 
an increase in overall knee compressive force of 144% (p=0.0003, Figure 3.34c).  
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Figure 3.34  Knee joint compressive forces (mean ± SD, n=12) using standard and revised optimisation: (a) 
medial, (b) lateral, (c) total force. 
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Table 3.7 Knee joint compressive forces (BW) during normal and FES gait 
Subjects Medial compressive 
force (BW) 
Lateral compressive 
force (BW) 
Total compressive force 
(BW) 
Normal 
gait 
FES gait Normal 
gait 
FES gait Normal gait FES gait 
1 1.44 1.18 0.75 3.90 2.16 5.02 
2 1.61 1.54 0.93 4.43 2.46 5.94 
3 1.49 1.47 1.12 5.11 2.52 6.57 
4 1.57 1.47 2.29 5.30 3.63 6.71 
5 1.80 2.04 1.09 5.17 2.81 7.17 
6 1.80 6.10 0.74 7.15 2.17 13.25 
7 1.54 1.33 0.65 2.31 2.12 3.61 
8 0.93 0.79 1.48 3.68 2.27 4.39 
9 1.13 0.98 1.60 3.09 2.64 4.07 
10 1.70 1.55 0.95 3.26 2.53 4.58 
11 1.59 1.58 0.93 4.79 2.40 6.08 
12 1.65 1.50 1.44 4.40 3.07 5.83 
Mean 1.52 1.79 1.16 4.38 2.56 6.10 
SD 0.26 1.39 0.47 1.27 0.44 2.52 
 
3.4 Discussion 
In healthy gait, the hamstrings, including BFLH, have their maximum activation during the 
swing phase. In late and terminal swing the hamstrings reduce the intensity of their activity 
so that excessive knee flexion is avoided at the end of the phase. Immediately after heel 
strike the ACL becomes loaded when the joint is close to maximum extension. Non-coping 
ACL deficient subjects maintain, or increase, hamstrings activity at this point through co-
contraction, in order to achieve normal gait (Rudolph et al., 2001; Shelburne et al., 2005). 
This theory of hamstrings co-contraction has been used in the development of technology 
to combine an ACL knee brace with hamstrings stimulation using FES to assist those with 
knee instability (Solomonow, 2006). It is likely that the selective activation of BFLH will 
be achievable through the use of such technology. Other work has shown that selective 
activation of muscles on the lateral aspect of the knee such as biceps femoris can also be 
used to delay medial knee osteoarthritis (Hodges et al., 2016). In this chapter, co-
contraction was created through the stimulation of BFLH throughout the stance phase.  
This chapter tested, using a combined modelling and experimental approach, the 
hypothesis that selective activation of the BFLH, one of the hamstrings, can theoretically 
and practically reduce the anterior tibial shear and tibial internal rotation torque at the 
knee. The hypothesis was derived due to the anatomy of the muscle, which attaches on the 
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fibular head that articulates with the lateral tibia and so has the potential to resist a large 
internal rotation moment and hence the pathological motion of the lateral compartment that 
occurs in ACL deficiency (Amis et al., 2005; Gao et al., 2010). We found that the anterior 
shear force and the tibial internal rotation torque were reduced when BFLH was stimulated 
with FES.  However, BFLH stimulation does not affect the knee adduction torque and 
flexion torque (Fig 3.20 (a) and (b), p>0.01). The pulsewidth of the FES stimulation across 
subjects ranged from 4 to 8 and there is no correlation between the levels of pulsewidth 
with their body mass. 
The modelling approach developed here used two optimisation methods to solve the 
muscle indeterminacy problem; both of these show that the peaks of reduction of tibial 
internal rotation torque occurred during weight acceptance, near full knee extension, which 
this is the time when the ACL is loaded.  
The reduction of the tibial internal rotation torque also indirectly affects the value of the 
anterior shear force (More et al., 1993). Theoretically, as BF inserts on the fibula, its 
activation in a flexed knee is able to pull the tibia posteriorly. In this study, the peak 
anterior shear force was significantly reduced when FES was applied during weight 
acceptance, before full knee extension. This work is consistent with the model simulation 
by Shelburne et al (2005) and the experimental study by Chen et al (2013) showing that by 
increasing the muscle activation of the hamstrings, ATT was reduced by 0.2cm with the 
knee in 20° to 50° of flexion. Also, in healthy gait body weight is transferred onto the 
forward limb in the weight acceptance phase. In contrast, for FES gait, the posterior pull of 
the extra activation of the BFLH by the FES resulting in slower than normal gait, as found 
in our study. After 80% of stance phase the posterior shear forces became elevated and, 
therefore to mitigate any detrimental posterior forces, the recommendation from this work 
would be that stimulation should stop after 80% of stance phase. This has been shown 
clearly in the results for all subjects (Figure 3.21-3.32) especially subject 7 (Figure 3.27).   
Here, the modelling cost function was modified from its standard form by assigning a 
weighting, c, to simulate BFLH stimulation. The value of c for each subject that reduced 
anterior shear force to zero was found and the mean value of c across all was 0.208. This 
mean value was then used, resulting in only one subject having a very small positive 
anterior shear force, demonstrating that the use of a mean value to simulate external 
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activation using FES is appropriate. This opens the way to clinical application without 
required significant personalisation of FES stimulation. The one subject with a higher c to 
decrease anterior shear force was the tallest and heaviest subject.  This work also follows 
the literature in which a similar c value of 0.25 was used to simulate the electrically 
stimulated muscle activation of gluteus medius to reduce the medial knee joint reaction 
force (Rane et al., 2016).  In the literature hamstrings activation without FES has shown 
that 56% of the maximal hamstring muscle force could reduce the ATT to a normal level 
during the stance phase of gait (Liu et al., 2000). That study modelled motions in the 
sagittal plane only and so cannot be compared for tibial internal rotation. Focusing on ATT 
only would suggest that the hamstrings on the medial side could also reduce anterior shear 
force and this has been shown in other modelling studies (Shelburne et al., 2005). 
However, as these do not assess tibial internal rotation torque, their results cannot be 
compared here. 
It should be noted that over activation of the hamstrings resulted in a higher knee contact 
force due to the co-contraction of the quadriceps muscles to overcome the flexion torque 
due to the hamstrings activation. This has been addressed by Catalfamo et al. (2010) who 
found that a 50% of stimulation of biceps femoris is more appropriate for reducing ATT 
compared to 100% stimulation due to the pathological increase in knee joint forces and this 
chapter has provided further evidence for this.  
This study has some limitations. Firstly, the experimental order was not randomised which 
may cause biase in the results. Secondly, the test cohort comprised only healthy control 
subjects; future work should focus on conducting experiments in ACL deficient subjects to 
test the applicability of this method in a clinical cohort. This is addressed in Chapter 5. It is 
expected that the results in such a cohort to be amplified as an ACL deficient subject 
would have reduced ability of the passive stabilisers to resist the ATT and internal rotation 
torque, thus emphasising the effect of the musculature. However, a confounding factor in 
ACL deficient subjects is that they already demonstrate altered muscle activation patterns 
that might result in a different pattern of internal rotation torque and anterior shear force 
(Berchuck et al., 1990; Gao et al., 2010; Rudolph et al., 1998). Thus, the following 
chapters will address these further discussed to cover these issues.  The effect of activation 
of BFLH in ACL deficient subjects and also the timing of activation and the effect of 
stimulation of other muscles will be presented in Chapter 4 and 5.  An investigation of 
compensatory muscle activations due to selective activation of BFLH, perhaps through the 
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use of electromyography is presented in Chapter 4. Secondly, the model used in this study 
is a non-subject specific model. The use of subject specific models would enable 
parameters such as muscle volume, maximum muscle stress and lines of action to be 
customised. This would enable, potentially, a greater fidelity of output to be achieved from 
the modelling. Thirdly, the use of static optimisation to determine the muscle forces needs 
to be further validated, as it may not reflect in vivo muscle force generation (Anderson et 
al., 2001), particularly in the FES condition. Finally, the application of a constant muscle 
activation for the whole of stance phase as achieved here is neither desirable, nor practical 
because muscle activation is changing accordingly during stance phase. Technology to 
allow selective activation at the peak of anterior tibial shear should be developed for 
appropriate clinical use.  
3.5 Conclusion 
This chapter presented a study which is the first to have shown that selective activation of 
the long head of biceps femoris can reduce the anterior tibial shear and tibial internal 
rotation torque at the knee in healthy subjects. A musculoskeletal model was modified to 
allow this analysis to take place. This approach opens the way for new rehabilitation 
therapies for ACL deficient subjects using functional electrical stimulation. The level of 
muscle activation predicted from the model to reduce the anterior tibial shear and tibial 
internal rotation torque in this chapter will be used for a study with ACL deficient and 
ACL reconstruction patients which will be presented in Chapter 5. 
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CHAPTER 4 2  
Validation of the FES Model during Gait 
This chapter explains the validation of the novel cost function to simulate functional 
electrical stimulation (FES) during gait. This chapter introduces a new method of 
validation that avoids functional electrical stimulation (FES) artefacts to allow the 
simultaneous measurement of EMG signals by identifying a pair of muscles where the 
stimulation of one is likely to have an effect on the activity of the second muscle. 
  
                                                            
2
Part of this chapter has been submitted for peer review publication, entitled  “Validation of a 
musculoskeletal gait model to study the role of functional electrical stimulation”, with authors: Nur Liyana 
Azmi, Ziyun Ding and Anthony M J Bull 
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4.1 Introduction 
Functional electrical stimulation (FES) has been used clinically to strengthen weak 
muscles by applying low level electrical currents (Peckham, 1987). FES can be used to 
treat patients with spinal cord injuries (SCI), anterior cruciate ligament (ACL) injuries and 
cerebral palsy (CP). For patients with SCI, short electrical pulses of FES stimulating 
paralyzed muscles are able to improve motor function (Lynch et al., 2008); for ACL 
injuries, FES on selected lateral hamstring muscles can improve knee stability (Chen et al., 
2013); and for CP, FES assists in reducing spasticity or contracting the involuntary muscle 
(Kerr et al., 2004). Inverse dynamics-based musculoskeletal modelling enables the 
quantification of muscle and joint forces based on measured inputs such as kinematics and 
external forces. Such models have been used preclinically to test FES’s ability in altering 
joint loading at the knee (Chapter 3) (Rane et al., 2016; Xu et al.). As these models require 
the use of an objective function to solve the indeterminacy of the musculoskeletal system 
that has more muscles available than necessary to drive the motion, the objective function 
should represent an appropriate physiological constraint. In the case of FES, alternative 
objective functions have been proposed (Rane et al., 2016; Xu et al.), yet these have not 
been validated to date. In Chapter 3, an alternative objective function was introduced to 
investigate the activation level of the biceps femoris long head (BFLH) in reducing the 
internal rotational torque and anterior shear at the knee in healthy subjects. 
Validation of musculoskeletal models is challenging (Erdemir et al., 2007). Validation can 
be achieved at the level of tendon forces, bone forces or joint contact forces using invasive 
devices, for example instrumented prostheses (Fregly et al., 2012) or tendon transducers 
(Bull et al., 2005). Non-invasive approaches are achievable by using surface 
electromyography (EMG) to validate the muscle activations calculated from the 
musculoskeletal model (Crowninshield et al., 1981; Erdemir et al., 2007). However, when 
combined with FES currents, EMG signals are affected. This has been partially addressed 
by others, where, for example, a shut-down circuit and an adaptive filter were used to 
remove the stimulation artefacts in a study using FES for tetraplegic patients (Sennels et 
al., 1997). Others have extracted the volitional EMG from a partially paralyzed muscle and 
used this to control other muscle stimulation (Frigo et al., 2000; Thorsen et al., 1999). 
However, none of these have been able to totally eliminate FES artefacts from the EMG 
signals (Frigo et al., 2000; Sennels et al., 1997).  
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The ability to apply FES and measure EMG simultaneously would likely only be possible 
if the muscle receiving stimulation through FES is located at a distance from the muscle 
whose EMG is being measured. It is therefore necessary to identify such a pair of muscles, 
where the stimulation of one is likely to have an effect on the activity of the second 
muscle.  
As shown in Chapter 3 stimulation of the BFLH thigh muscle using FES has been used 
clinically to treat ACL deficient and ACL reconstructed patients (Snyder-Mackler et al., 
1991), to improve spinal cord injury patients in walking (Mohr et al., 1997), and in 
cerebral palsy to assist in standing (Carmick, 1997). BFLH acts as a knee flexor, but can 
also compensate for weak hip extensors such as gluteus maximus (Jonkers et al., 2003). In 
addition, the primary compensatory muscles for hamstrings weakness are gluteus 
maximus, the vasti (Komura et al., 2004) and iliacus psoas (Ardestani et al., 2016). The 
vasti are located near to BFLH and the measured signal with EMG could easily be affected 
by FES current. The iliacus psoas is not superficial and so cannot be measured by surface 
EMG. Therefore, a likely clinically-relevant candidate for muscle stimulation is BFLH and 
it is hypothesised that gluteus maximus will then increase its activity, and is sufficiently far 
removed from BFLH to allow its activity to be measured with EMG. The hypothesis of this 
chapter is that FES-assisted activation of BFLH during gait increases the activation of 
gluteus maximus, and that the EMG signals of gluteus maximus are clean from FES 
artefacts, because of its distance from the FES electrodes. 
The aim of this chapter is to  
1. understand the compensatory gluteus maximus muscle activations  due to activation 
of BFLH with  FES; and 
2. validate a musculoskeletal model that quantifies and evaluates the effect of FES on 
BFLH through measuring EMG of gluteus maximus muscles. 
4.2 Methods and Materials 
The hypotheses were tested through the application of three different FES current 
stimulation levels (40 mA, 60 mA and 80 mA) to the BFLH of healthy subjects and 
through the simultaneous measurement of the EMG of gluteus maximus. In this pilot 
study, fifteen healthy subjects (6 males and 9 females; mean height 1.64±0.12m; mass 
64.0±12.46 kg; age 26.9±3.39 years) participated in the study (Table 4.1). This study was 
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approved by the institutional research ethics committee of Imperial College London (Date: 
4 August 2014) and written informed consent was obtained from all participants.  
Table 4.1 Anthropometric data of the subjects 
Subject Height (m) Mass (kg) Age (year) 
1 1.59 69.00 22 
2 1.82 71.20 26 
3 1.59 51.50 33 
4 1.71 63.50 27 
5 1.53 70.80 30 
6 1.54 58.10 28 
7 1.73 68.40 25 
8 1.67 62.80 24 
9 1.53 50.20 20 
10 1.65 52.70 27 
11 1.77 68.20 28 
12 1.89 100.90 26 
13 1.62 60.80 31 
14 1.51 55.50 30 
15 1.54 56.30 27 
Mean 1.64 63.99 26.93 
SD 0.12 12.46 3.39 
 
Data Collection 
Kinematic and kinetic data were captured in a motion analysis laboratory. Eighteen retro-
reflective markers were placed on the pelvis and the right lower limb (Duffell et al., 2014) 
(Figure 3.6 and Table 3.2 in Section 3.2). Their trajectories were captured at 200 Hz using 
a ten-camera motion capture system (Vicon Motion Systems Ltd, Oxford, UK). Ground 
reaction forces of the right lower limb were measured at 1000 Hz from a force plate 
(Kistler Type 9286BA, Kistler Instrument AG, Winterthur, Switzerland). After six over 
ground walking trials, FES electrodes (Odstock 2 Channel Stimulator, Odstock Medical 
Ltd., UK) were placed on the subject’s BFLH: one at the bottom and the other at the centre 
of the BFLH, with a distance of two hand widths between them. The FES pulse widths 
could be set at a level of between 0 to 350µs, corresponding to a manufacturer-defined 
range of 0-9. This was set with an average level of three according to subjects’ tolerance 
towards the current stimulations. The frequency of the stimulator was 40 Hz as 
recommended by the FES manufacturer, and the intensity was adjusted to the maximum 
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level that each subject was able to comfortably withstand (Lynch et al., 2008). Similar to 
the initial over ground walking trial, subjects walked in a self-selected comfortable speed 
with three FES stimulation currents, which were initialised at 40 mA and increased to 
60 mA and finally to 80 mA. The subjects were allowed to rest between trials. Walking 
trials were repeated six times at each current level. The stimulation current was set to start 
with one second of ramp up, followed by four seconds of maximum current level and then 
ending with one second of ramp down. The stimulator was manually started by the subject 
and timed so that the stimulation current was at its maximum value when the right foot 
stepped on the force plate, through heel strike and toe off.  
Surface EMG sensors (Delsys, Trigno Wireless EMG System, USA) were placed 
according to SENIAM recommendations (Hermens et al., 2000) on the BFLH (the 
electrodes were placed halfway along the line between the ischial tuberosity and the lateral 
epicondyle of the tibia) and gluteus maximus (the electrodes were placed halfway along 
the line between the sacral vertebrae and the greater trochanter) of the right leg (Figure 
4.1). The skin was treated with isopropyl alcohol prior to sensor application to ensure low 
impedance. For the first trial, an EMG sensor was attached over the BFLH. This was then 
replaced with the FES electrodes for the second and subsequent walking trials. Raw EMG 
data was band-pass filtered (30-300Hz), whole wave rectified, and normalized to the 
maximum EMG signal of each particular subject (Buchanan et al., 2004). 
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Figure 4.1  EMG and FES electrode positions 
 
Lower Limb Musculoskeletal Model 
Similar to Chapter 3, the open source musculoskeletal modelling software Freebody V2.1 
was used in this chapter (Cleather et al., 2015; Ding et al., 2016). The same standard 
optimisation (Equation 3.1 & Equation 3.2) was performed using the standard cost function 
in order to minimize the sum of the cubed muscle activations (Crowninshield et al., 1981): 
Optimisation Method 
In order to simulate the effect of three FES current levels applied to BFLH, the same 
revised optimisation method (Equation 3.3 & Equation 3.4) in Chapter 3 was used. In this 
chapter, the c value to present 40mA, 60mA and 80mA current stimulations was set as 
0.10, 0.15 and 0.20, respectively; these were all higher than the muscle activation of BFLH 
predicted from standard optimisation.  
Data Analysis 
Stance phase was expressed over a 0-100% duration with a step interval of 1%. This was 
then further divided into four sub-phases (Perry et al., 2010): initial contact (0-3%), 
loading response (4-19%), mid stance (20-50%) and terminal stance (51-100%).  
Gluteus maximus 
Biceps femoris 
long head 
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The gluteus maximus activations predicted from the model and its EMG signals were 
averaged over three trials and presented as a mean value. Correlations of determination 
(R
2
) were calculated between the predicted gluteus maximus muscle activations and its 
EMG data in terms of their peak values and the areas under the curve in each sub-phase of 
the stance. All data were analysed using MATLAB (R2015b. The MathWorks Inc., USA).  
4.3 Results 
All subjects tolerated all tests at 40mA and 60mA stimulation. One subject did not tolerate 
80mA stimulation, therefore, data at 80mA are presented from 14/15 subjects.  In normal 
walking and in FES applied walking, the gluteus maximus muscle activation predicted 
from models across all subjects is shown in Figure 4.2 and its EMG measurement is shown 
in Figure 4.3. Higher c values in the optimisation function contribute to greater gluteus 
maximus activation. A similar trend of its activity was found from the measured EMG. The 
gluteus maximus muscle activations predicted from modelling and the measured EMG of 
all subjects are shown in Appendix B. 
 
Figure 4.2 Model predictions of gluteus maximus muscle activations (mean±SD, n=15). Standard 
optimisation refers to muscle activations during normal walking, and revised optimisation presents the 
muscle activations during FES applied walking 
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Figure 4.3 Gluteus maximus EMG measurements (mean±SD, n=15) in normal walking and FES applied 
walking 
Predicted peak activation and maximum EMG measurement of the gluteus maximus are 
highly correlated, with the R
2
 values ranging from 0.73 to 0.99 and R values ranging from 
0.86 to 0.995 (Figure 4.4, Table 4.2). The peak gluteus maximus activations for all subjects 
calculated by musculoskeletal modelling and as measured by EMG are shown below 
during the four sub-phases: initial contact (Table 4.3), loading response (Table 4.4), mid 
stance (Table 4.5) and terminal stance (Table 4.6).  
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(a) Initial contact (0-3%) (b) Loading response (4-19%) 
  
(c) Mid stance (20-50%) (d) Terminal stance (51-100%) 
 Standard Optimisation, Without FES   c=0.10, 40 mA   c=0.15, 60 mA  c=0.20, 80 mA  
Figure 4.4 Correlations between predicted peak gluteus maximus activation and its measured peak EMG 
signals in each sub-phase of the stance phase: (a)-(d). The four datapoints in each graph represent normal 
walking, and FES applied walking with FES currents of 40 mA, 60 mA and 80 mA 
Table 4.2 Peak gluteus maximus activations calculated by musculoskeletal modelling and as measured by 
EMG during the stance phase of normal walking and FES applied walking. c values of 0.10, 0.15 and 0.20 in 
models represent FES currents of 40 mA, 60 mA and 80 mA, respectively (mean ± SD), N=15) 
Stance phase  
(%) 
 Model predictions  EMG 
 No FES  c=0.10  c=0.15  c=0.20  No FES  40mA 60 mA  80mA 
0-3% 0.01 
±0.01 
0.02 
±0.01 
0.03 
±0.02 
0.04 
±0.03 
0.19 
±0.15 
0.21 
±0.17 
0.24 
±0.17 
0.25 
±0.19 
4-19% 0.06 
±0.02 
0.07 
±0.02 
0.08 
±0.02 
0.08 
±0.04 
0.28 
±0.17 
0.35 
±0.21 
0.34 
±0.17 
0.36 
±0.20 
20-50% 0.06 
±0.02 
0.08 
±0.26 
0.09 
±0.02 
0.10 
±0.04 
0.30 
±0.17 
0.40 
±0.19 
0.40 
±0.20 
0.43 
±0.23 
51-100% 0.04 
±0.14 
0.06 
±0.02 
0.06 
±0.01 
0.06 
±0.02 
0.21 
±0.14 
0.32 
±0.18 
0.32 
±0.15 
0.35 
±0.23 
R² = 0.9694 
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Table 4.3 Peak gluteus maximus activations calculated by musculoskeletal modelling and as measured by 
EMG during initial contact (0-3% of stance phase) of normal walking and FES applied walking.   
Subject 
Model predictions EMG  
No FES c = 0.1 c = 0.15 c = 0.20 No FES 40 mA 60 mA 80 mA 
1 0.0067 0.0132 0.0105 0.0219 0.2064 0.1674 0.2205 0.1980 
2 0.0033 0.0169 0.0470 0.0484 0.4374 0.3727 0.4399 0.5887 
3 0.0094 0.0387 0.0562 0.0892 0.0607 0.1189 0.1541 0.1747 
4 0.0186 0.0276 0.0427 0.0604 0.0615 0.0395 0.0523 0.0502 
5 0.0087 0.0205 0.0377 0.0713 0.2016 0.1490 0.3373 0.3693 
6 0.0065 0.0210 0.0239 0.0649 0.3151 0.1929 0.3528 0.3951 
7 0.0152 0.0386 0.0551 0.0716 0.1257 0.1506 0.1536 0.1492 
8 0.0039 0.0220 0.0404 0.0000 0.0851 0.0695 0.1215 0.0000 
9 0.0007 0.0081 0.0130 0.0183 0.5052 0.3752 0.3688 0.4386 
10 0.0031 0.0055 0.0027 0.0008 0.2422 0.2976 0.2287 0.2357 
11 0.0022 0.0079 0.0135 0.0174 0.0887 0.0917 0.0825 0.0825 
12 0.0041 0.0109 0.0053 0.0030 0.0048 0.1166 0.1270 0.0694 
13 0.0128 0.0322 0.0412 0.0056 0.2341 0.7000 0.7020 0.5776 
14 0.0057 0.0179 0.0314 0.0452 0.1800 0.2570 0.1846 0.2450 
15 0.0039 0.0246 0.0308 0.0462 0.0531 0.0678 0.0916 0.1184 
Mean 0.0070 0.0204 0.0301 0.0376 0.1868 0.2111 0.2411 0.2462 
SD 0.0051 0.0106 0.0177 0.0299 0.1446 0.1718 0.1731 0.1874 
 
Table 4.4 Peak gluteus maximus activations calculated by musculoskeletal modelling and as measured by 
EMG during loading response (4-19% stance phase) of normal walking and FES applied walking 
Subject 
Model predictions EMG  
No FES c = 0.1 c = 0.15 c = 0.20 No FES 40 mA 60 mA 80 mA 
1 0.0374 0.0481 0.0584 0.0610 0.2416 0.2398 0.3335 0.2980 
2 0.0591 0.0539 0.0759 0.0914 0.6203 0.6306 0.6015 0.8103 
3 0.0700 0.0933 0.1006 0.1370 0.2583 0.3507 0.2667 0.3599 
4 0.0716 0.0717 0.0823 0.0973 0.3089 0.2770 0.3346 0.3029 
5 0.0528 0.0656 0.0835 0.0951 0.3281 0.3571 0.3727 0.4143 
6 0.0392 0.0508 0.0678 0.0846 0.3594 0.2978 0.3796 0.4967 
7 0.0795 0.1033 0.1298 0.1513 0.1886 0.2190 0.1803 0.2309 
8 0.0534 0.0676 0.0838 - 0.1297 0.0963 0.1887 - 
9 0.0317 0.0417 0.0532 0.0644 0.5969 0.5010 0.4866 0.5761 
10 0.0522 0.0499 0.0555 0.0665 0.4164 0.4119 0.3199 0.3706 
11 0.0792 0.0608 0.0558 0.0733 0.1306 0.1979 0.2157 0.1997 
12 0.0712 0.0568 0.0622 0.0538 0.0069 0.1822 0.2531 0.1461 
13 0.0433 0.0709 0.0770 0.0502 0.2474 0.9044 0.7592 0.5781 
14 0.0637 0.0775 0.0878 0.0966 0.3147 0.4336 0.3181 0.4327 
15 0.0697 0.0913 0.1015 0.1249 0.0648 0.1042 0.1431 0.2169 
Mean 0.0583 0.0669 0.0783 0.0832 0.2808 0.3469 0.3435 0.3622 
SD 0.0155 0.0182 0.0212 0.0378 0.1738 0.2127 0.1657 0.2017 
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Table 4.5 Peak gluteus maximus activations calculated by musculoskeletal modelling and as measured by 
EMG during mid stance (20-50% stance phase) of normal walking and FES applied walking 
Subject 
Model predictions EMG  
No FES c = 0.1 c = 0.15 c = 0.20 No FES 40 mA 60 mA 80 mA 
1 0.0406 0.0655 0.0680 0.0751 0.2172 0.2448 0.3192 0.2989 
2 0.0599 0.0649 0.0833 0.1005 0.5295 0.6142 0.5583 0.7291 
3 0.0751 0.0977 0.1191 0.1496 0.2471 0.3387 0.2614 0.3137 
4 0.0733 0.0757 0.0896 0.1129 0.4989 0.5782 0.6926 0.5679 
5 0.0611 0.0837 0.0920 0.1023 0.3789 0.5510 0.4303 0.4486 
6 0.0422 0.0549 0.0728 0.0884 0.2981 0.4358 0.5146 0.6428 
7 0.0809 0.1098 0.1382 0.1645 0.1569 0.1728 0.1296 0.1892 
8 0.0642 0.1493 0.1182 - 0.1260 0.0956 0.1738 - 
9 0.0372 0.0543 0.0678 0.0788 0.5427 0.4904 0.4662 0.5483 
10 0.0594 0.0522 0.0608 0.0723 0.4063 0.3603 0.3082 0.3554 
11 0.0949 0.0811 0.0860 0.1025 0.4905 0.6739 0.8420 0.7558 
12 0.0738 0.0857 0.1027 0.0856 0.0066 0.1938 0.2577 0.1696 
13 0.0423 0.0759 0.0828 0.0546 0.2145 0.6904 0.4827 0.4999 
14 0.0654 0.0861 0.0992 0.1085 0.3242 0.4005 0.3767 0.6350 
15 0.0776 0.1057 0.1141 0.1386 0.0617 0.2183 0.1539 0.2322 
Mean 0.0632 0.0828 0.0930 0.0956 0.2999 0.4039 0.3978 0.4258 
SD 0.0169 0.0256 0.0222 0.0399 0.1724 0.1924 0.2020 0.2247 
 
Table 4.6 Peak gluteus maximus activations calculated by musculoskeletal modelling and as measured by 
EMG during terminal stance (51-100% stance phase) of normal walking and FES applied walking 
Subject Model predictions EMG  
No FES c = 0.1 c = 0.15 c = 0.20 No FES 40 mA 60 mA 80 mA 
1 0.0433 0.0541 0.0609 0.0694 0.1402 0.1609 0.1537 0.1758 
2 0.0386 0.0470 0.0563 0.0582 0.2142 0.2834 0.3043 0.4208 
3 0.0195 0.0446 0.0544 0.0619 0.1693 0.4209 0.3428 0.3577 
4 0.0328 0.0421 0.0490 0.0553 0.2350 0.2854 0.2765 0.2039 
5 0.0626 0.0824 0.0832 0.0873 0.3285 0.3932 0.4493 0.5004 
6 0.0298 0.0396 0.0456 0.0490 0.2985 0.3345 0.4934 0.6462 
7 0.0427 0.0584 0.0689 0.0822 0.0595 0.1398 0.0812 0.0938 
8 0.0620 0.1241 0.0647 - 0.0667 0.0470 0.1571 - 
9 0.0232 0.0370 0.0418 0.0528 0.3612 0.3177 0.3574 0.3533 
10 0.0210 0.0376 0.0456 0.0557 0.1752 0.1641 0.2104 0.1816 
11 0.0428 0.0694 0.0704 0.0745 0.4821 0.5291 0.6890 0.6782 
12 0.0563 0.0660 0.0808 0.0746 0.0045 0.2315 0.2553 0.1211 
13 0.0263 0.0366 0.0368 0.0442 0.1417 0.3257 0.3324 0.4466 
14 0.0309 0.0505 0.0637 0.0645 0.3494 0.3195 0.4278 0.7476 
15 0.0447 0.0625 0.0645 0.0785 0.0796 0.7991 0.3229 0.2767 
Mean 0.0384 0.0568 0.0591 0.0605 0.2071 0.3168 0.3236 0.3469 
SD 0.0140 0.0231 0.0138 0.0210 0.1346 0.1804 0.1526 0.2262 
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Predicted gluteus maximus activation impulse and measured EMG impulse were highly 
correlated, with the R2 values ranging from 0.84 to 0.96 and R values ranging from 0.92 to 
0.98 (Table 4.7, Figure 4.5). The predicted gluteus maximus activation impulses for all 
subjects calculated by musculoskeletal modelling and as measured by EMG are shown 
below during the four sub-phases: initial contact (Table 4.8), loading response (Table 4.9), 
mid stance (Table 4.10) and terminal stance (Table 4.11). 
  
(a) Initial contact (0-3%) (b) Loading response (4-19%) 
  
(c) Mid stance (20-50%) (d) Terminal stance (51-100%) 
 Standard Optimisation, Without FES   c=0.10, 40 mA   c=0.15, 60 mA  c=0.20, 80 mA  
Figure 4.5 Correlations between predicted gluteus maximus activation impulse (area under the curve) and 
measured EMG impulse in each sub-phase of the stance phase : (a)-(d). The four datapoints in each graph 
represent normal walking, and FES applied walking with FES currents of 40 mA, 60 mA and 80 mA. 
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Table 4.7 Gluteus maximus activation impulse calculated by musculoskeletal modelling and as measured by 
EMG during the stance phase of normal walking and FES applied walking. c values of 0.10, 0.15 and 0.20 in 
models represent FES currents of 40 mA, 60 mA and 80 mA, respectively (mean ± SD, n=15) 
Impulse (area under the curve) 
Stance 
phase (%) 
Model predictions EMG 
No 
FES 
 c=0.10 c=0.15 c=0.20 No 
FES 
 40mA  60 mA  80mA 
0-3% 0.01 
±0.01 
0.03 
±0.02 
0.05 
±0.03 
0.07 
±0.05 
0.52 
±0.41 
0.58 
±0.47 
0.68 
±0.50 
0.70 
±0.53 
4-19% 0.52 
±0.16 
0.61 
±0.22 
0.72 
±0.26 
0.82 
±0.39 
3.70 
±2.50 
4.39 
±3.11 
4.51 
±2.47 
4.75 
±2.82 
20-50% 1.44 
±0.40 
2.11 
±0.67 
2.36 
±0.52 
2.46 
±0.71 
6.66 
±3.92 
8.81 
±4.37 
9.14 
±5.06 
10.13 
±5.02 
51-100% 1.39 
±0.49 
2.07 
±0.87 
2.12 
±0.60 
2.18 
±0.66 
7.00 
±4.22 
9.20 
±3.78 
10.42 
±5.99 
11.66 
±8.01 
 
Table 4.8 Gluteus maximus activation impulse calculated by musculoskeletal modelling and as measured by 
EMG during initial contact (0-3% stance phase) 
Subject Model predictions EMG  
No FES c= 0.1 c = 0.15 c = 0.20 No FES 40 mA 60 mA 80 mA 
1 0.0067 0.0252 0.0195 0.0408 0.5851 0.4686 0.6034 0.5416 
2 0.0053 0.0305 0.0838 0.0869 1.1871 1.0062 1.2213 1.6309 
3 0.0106 0.0502 0.0803 0.1357 0.1509 0.3283 0.4396 0.5008 
4 0.0232 0.0446 0.0733 0.1052 0.1612 0.1078 0.1433 0.1361 
5 0.0142 0.0398 0.0740 0.1308 0.5739 0.4296 0.9964 1.0902 
6 0.0116 0.0395 0.0433 0.1160 0.8909 0.5577 1.0421 1.1590 
7 0.0195 0.0676 0.0941 0.1293 0.3369 0.4040 0.4325 0.3965 
8 0.0036 0.0286 0.0588 - 0.2330 0.1942 0.3279 - 
9 0.0009 0.0137 0.0213 0.0283 1.4360 1.0606 1.0301 1.2293 
10 0.0028 0.0060 0.0023 0.0008 0.6448 0.8059 0.6383 0.6455 
11 0.0013 0.0104 0.0190 0.0250 0.2651 0.2660 0.2389 0.2359 
12 0.0045 0.0166 0.0045 0.0059 0.0133 0.3213 0.3334 0.1986 
13 0.0179 0.0607 0.0791 0.0088 0.6783 1.9226 1.9901 1.7222 
14 0.0083 0.0326 0.0580 0.0838 0.4739 0.6790 0.5041 0.6571 
15 0.0038 0.0485 0.0588 0.0819 0.1507 0.1891 0.2492 0.3208 
Mean 0.0089 0.0343 0.0513 0.0653 0.5187 0.5827 0.6794 0.6976 
SD 0.0070 0.0182 0.0308 0.0502 0.4062 0.4703 0.4952 0.5272 
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Table 4.9 Gluteus maximus activation impulse calculated by musculoskeletal modelling and as measured by 
EMG during loading response (4-19% stance phase) 
Subject Model predictions EMG  
No FES c = 0.1 c = 0.15 c = 0.20 No FES 40 mA 60 mA 80 mA 
1 0.3818 0.4089 0.4507 0.5215 3.4903 3.2564 4.5640 4.0907 
2 0.4461 0.3716 0.6632 0.8107 8.6482 8.4022 8.4650 11.3717 
3 0.6868 1.0475 1.0642 1.5948 2.7124 3.7753 3.3626 4.4312 
4 0.7403 0.7186 0.8600 1.0561 2.5093 1.9397 2.3986 2.2264 
5 0.4904 0.6222 0.8572 1.1659 4.1206 3.5202 5.4174 5.9583 
6 0.3302 0.4985 0.5921 0.9417 5.1323 3.5865 5.5030 6.7490 
7 0.7875 0.9779 1.2896 1.4553 2.5950 3.0250 2.5182 3.1617 
8 0.4554 0.5093 0.6747 - 1.7673 1.3344 2.5753 - 
9 0.2241 0.2869 0.4224 0.6036 8.6359 7.0236 6.9129 8.1673 
10 0.3561 0.4432 0.4326 0.4918 5.5620 5.7966 4.4702 5.0174 
11 0.6121 0.4832 0.5192 0.7037 1.5227 1.9084 1.9210 1.9098 
12 0.7118 0.5134 0.4122 0.3321 0.0953 2.3686 3.1595 1.6087 
13 0.4973 0.7403 0.7500 0.4473 3.5940 12.6670 10.2996 8.1813 
14 0.5410 0.6390 0.7873 0.9714 4.2007 5.8683 4.1160 5.6586 
15 0.5542 0.8358 0.9644 1.2467 0.9342 1.3243 1.9318 2.7013 
Mean  0.5210 0.6064 0.7160 0.8229 3.7013 4.3864 4.5077 4.7489 
SD 0.1637 0.2212 0.2600 0.3903 2.5012 3.1124 2.4722 2.8231 
 
Table 4.10  Gluteus maximus activation impulse calculated by musculoskeletal modelling and as measured 
by EMG during mid stance (20-50% stance phase) 
Subject Model predictions EMG  
No FES c= 0.1 c = 0.15 c = 0.20 No FES 40 mA 60 mA 80 mA 
1 1.1129 1.7377 1.9267 2.0478 5.7420 6.5876 6.8776 8.0239 
2 1.1892 1.7144 2.1222 2.4872 7.9708 11.7158 11.9261 14.6580 
3 1.4209 2.3039 2.8262 3.4820 5.5470 6.1278 6.1180 6.2914 
4 1.4841 1.9267 2.3292 2.8964 12.2588 13.9100 16.1900 13.1195 
5 1.5868 2.1972 2.5012 2.8109 10.5906 14.6508 12.1451 13.1308 
6 1.0737 1.4469 1.8409 2.1838 7.2700 11.6775 14.0564 17.1528 
7 1.8484 2.7216 3.3788 4.1312 2.1529 2.2632 2.2129 2.4549 
8 1.5969 3.9877 2.9228 - 2.3289 2.1797 2.5492 - 
9 0.8004 1.3501 1.6109 1.9947 12.2161 12.2459 12.0267 12.7004 
10 1.2206 1.4365 1.6682 2.0316 8.1255 7.2035 5.6180 6.9437 
11 2.2018 2.2533 2.3206 2.7793 10.5644 15.9879 19.3070 16.9269 
12 1.8384 2.2469 2.7065 2.3191 0.1416 5.2896 5.7015 3.9898 
13 0.8883 1.6425 1.8767 1.4404 4.6849 7.8228 7.7078 14.6079 
14 1.4232 2.0965 2.5059 2.8516 8.7739 9.0316 10.3453 15.8534 
15 1.8466 2.6582 2.8773 3.4227 1.5999 5.3900 4.3499 6.1497 
Mean 1.4355 2.1147 2.3609 2.4586 6.6645 8.8056 9.1421 10.1335 
SD 0.3951 0.6710 0.5203 0.7133 3.9167 4.3652 5.0619 5.0211 
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Table 4.11 Gluteus maximus activation impulse calculated by musculoskeletal modelling and as measured by 
EMG during loading response (51-100%) 
Subject Model predictions EMG  
No FES c= 0.1 c = 0.15 c = 0.20 No FES 40 mA 60 mA 80 mA 
1 1.5848 2.2420 2.4382 2.8301 4.9354 5.2356 5.9163 5.4256 
2 1.3551 1.7552 2.1042 2.2494 8.7736 11.6922 13.7329 19.2199 
3 0.7089 1.2752 1.5405 1.8903 5.4198 14.6855 12.0843 13.2736 
4 1.4286 1.7313 1.9114 2.2258 5.4779 5.4473 5.5621 4.8838 
5 2.3375 3.1810 3.4315 3.6535 10.2224 14.2096 21.6455 22.9398 
6 0.9445 1.3374 1.5961 1.7755 11.9562 12.0004 21.9256 27.5479 
7 1.5624 2.0171 2.2333 2.4978 1.9945 5.3127 3.1256 3.0359 
8 1.9017 4.4751 2.0074 - 2.7235 2.0077 5.0485 - 
9 0.9539 1.4767 1.6521 1.8894 13.9756 12.1630 12.6562 13.3778 
10 0.6536 0.9934 1.2514 1.2292 7.0164 7.0765 7.5348 7.6651 
11 1.6688 2.4234 2.5521 2.5723 11.5626 9.8446 11.8356 12.1854 
12 1.9420 2.4464 2.9493 2.8995 0.1771 6.4401 3.9369 2.1436 
13 0.9680 1.3935 1.3773 1.4418 6.5591 8.7490 12.1121 20.1439 
14 1.1485 2.0233 2.4619 2.7559 11.6877 12.3313 14.2151 17.1329 
15 1.6551 2.2825 2.3032 2.8576 2.5143 10.8367 5.0272 5.8717 
Mean 1.3876 2.0702 2.1206 2.1845 6.9997 9.2021 10.4239 11.6565 
SD 0.4865 0.8749 0.6006 0.6554 4.2159 3.7786 5.9868 8.0102 
4.4 Discussion 
This chapter has experimentally validated an algorithm implemented in a musculoskeletal 
model to simulate the effect of FES stimulation and has shown that FES-assisted activation 
of BFLH during gait proportionally increases the activation of gluteus maximus. 
Gluteus maximus, together with gastrocnemius, are the muscles which compensate for 
weakness of the BFLH to restore control at the hip during stance phase (Jonkers et al., 
2003). Other studies have shown that the primary compensatory muscles for hamstrings 
weakness are gluteus maximus, the vasti (Komura et al., 2004) and iliacus psoas (Ardestani 
et al., 2016). In this chapter, the gluteus maximus was chosen as the candidate for 
measuring EMG for two reasons: it is positioned at a distance from BFLH and it shares 
function with BFLH as a hip extensor (Kendall et al., 1993; Perry et al., 2010). The results 
show that FES artefact signals from the stimulated BFLH did not affect the EMG readings 
at gluteus maximus. 
Both mean peak gluteus maximus muscle activation predicted from the models and mean 
peak gluteus maximus activity from EMG measurement occurred during mid stance (20-
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50% of stance phase; Table 4.2); prior work has also shown that this takes place in mid 
stance (Winter et al., 1987). 
In this study, the musculoskeletal modelling cost function was modified from its standard 
form by assigning and weighting a variable, c, to simulate the BFLH as previously 
presented in Chapter 3. In Chapter 3, the value of c for each subject that reduced anterior 
shear force to zero was found and the mean value of c across all subjects was 0.208 for 
40mA FES current stimulation. In this chapter, the FES current stimulation was set to three 
different levels. The c values chosen for the FES gait set of 40, 60 and 80 mA were 0.10, 
0.15 and 0.20 respectively. These were chosen to mimic the incremental increase in BFLH 
activation caused by the different levels of FES current stimulation and to reach the level 
of 0.20 which corresponds to the level found in Chapter 3. The incremental increase in 
BFLH activation was found from the increasing EMG signals of the gluteus maximus.  
This study has found statistical correlations between peak and impulse of gluteus maximus 
activation between modelling and EMG signals (Figure 4.4, Figure 4.5). These correlations 
provide a level of validation for the algorithm used in the musculoskeletal model and show 
that FES stimulation potentially can be tuned to a level to achieve different outcomes. This 
dose-response relationship can be harnessed for clinical benefit in many different lower 
limb pathologies.  
The literature highlights that during loading response, when the hamstrings action is 
reduced, the gluteus maximus activity should be increased to provide hip stability (Perry et 
al., 2010). Interestingly, in the study shown here, gluteus maximus activity increased with 
increasing activation of the BFLH using FES during walking. This increased activity of the 
gluteus maximus activity occurred because the BFLH and gluteus maximus actions are 
multi joint processes. The gluteus maximus and hamstrings are the hip extensor and knee 
flexors respectively and have increasing activity in late swing to control the forward 
movement of the swinging lower limb (Winter et al., 1987). Moreover, the hip extensor 
muscles have two functions, firstly to decelerate the limb’s momentum in terminal swing 
to prepare for stance, and secondly to restrain the forward momentum of the pelvis and 
trunk as the limb is loaded (Perry et al., 2010). In addition, during stance phase, the 
primary muscles controlling the hip are the extensors and abductors, which include the 
gluteus maximus. The extra activation of the BFLH with FES in this study forced gluteus 
maximus activity to be activated from late mid swing through the loading response more 
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than usual. As the hamstrings and gluteus maximus have a complementary role as the 
plantar flexors, this might also change not only the kinematics of the foot (Jonkers et al., 
2003) but also of the knee and hip during early stance phase. Both BFLH and gluteus 
maximus also assist in lateral rotation of the tibia. These multi-joint actions provide an 
explanation for why the extra activation of BFLH with FES contributes to such large 
changes to gluteus maximus muscle activity.  
There are some limitations to this study. Firstly, the trials were not in a randomised order 
which may introduce an experimental bias. Secondly, FES was not comfortable for some 
subjects and the stimulation pulse width was set differently according to subject tolerance 
and could be due to different muscle thicknesses between subjects. None of the subjects   
complained about the pain caused by the FES during the study until the FES current was 
set to 80mA; at this highest level it was possible that some subjects may have changed 
their walking patterns, however, this was not analysed in this study. Thirdly, there may 
also have been a cross talk in EMG measurements due to electrode placement of the EMG 
sensors. This minor difference in EMG placement on the gluteus maximus may have 
caused the EMG sensors to pick up signals from neighbouring muscles. This study 
assumed that any signal interference from neighbouring muscles would be minimal in 
comparison to the gluteus maximus. Lastly, this study also does not take into account any 
differences in cadence or walking speed, which may affect the results, particularly at 
higher values of FES current. In the future, other muscles should be considered, for 
example the gastrocnemius and the tibialis anterior, which may also compensate for the 
extra stimulation of BFLH muscles and will present more complete results. 
4.5 Conclusion 
This chapter presents the investigation to show how the activation of the BFLH correlates 
with the muscle activity of the gluteus maximus. The results from this study also validate a 
musculoskeletal modelling method that can simulate FES during gait. This musculoskeletal 
model can be used to predict muscle activation for any clinical study using FES including 
the use of FES to reduce the knee instability of the ACL deficient knee during stance 
phase, which will be presented in Chapter 5. 
  
86 
 
 
 
 
 
 
 
 
CHAPTER 5   
Musculoskeletal model to investigate the use of FES at the ACLD and ACLR knee 
This chapter compares the differences in kinematics and kinetics between healthy, ACL 
deficient and ACL reconstructed subjects during the stance phase of gait with and without 
FES stimulation of the BFLH by means of physical experiments and musculoskeletal 
modelling.  
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5.1 Introduction  
As described in Chapter 2, an ACL tear or rupture results in an increase in tibiofemoral 
laxity of the knee in which the tibia has greater anterior tibial translation (ATT) and 
internal rotation than the normal movement of a healthy knee with an intact ACL. ACL 
deficient (ACLD) patients not only have this abnormal laxity, but also have a tibial anterior 
translation and external rotation offset relative to their contralateral knee (Andriacchi et al., 
2005). For these individuals it is hypothetically possible that the abnormal articular 
kinematics due to the loss of the ACL can be compensated by appropriate muscle firing 
during walking. This could not only restore knee stability, but also potentially avoid further 
degenerative changes of the knee, such as meniscal tears and articular cartilage 
degeneration.  
The maximum peak values of the anterior tibial shear occurs during mid stance (20-50% of 
the stance phase) at approximately 25% of stance phase (Alkjaer et al., 2011) and 
maximum internal tibial rotational torques occur during heel strike (0-3% of the stance 
phase) (Andriacchi et al., 2005). Despite these known loading conditions and the known 
function of the ACL, some ACLD patients can functionally cope with their injury (copers) 
and others do not (non-copers). The copers are able to return to pre-injury activity without 
surgical intervention and non-copers require surgery to achieve the same outcome. The 
copers limit ATT by: reducing their quadriceps contraction and maintaining lower levels of 
knee joint flexion (Berchuck et al., 1990) or by having a higher knee flexion combined 
with hamstrings contraction to prevent abnormal ATT and to reduce internal rotation 
torque (Benedetti et al., 1999). Non-copers are known to have reduced compression and 
anterior shear force at the knee joint (Alkjaer et al., 2011) and have difficulty to even flex 
their knees (Rudolph et al., 1998).  
The treatment for ACL injury is based on the level of injury diagnosed by surgeons; 
treatment is either rehabilitation alone, or ACL reconstruction (ACLR) surgery plus 
rehabilitation. Rehabilitation for ACL injury is focused on strengthening of the quadriceps 
muscles due to the ‘quadriceps avoidance’ mechanism for ACL rupture that causes 
quadriceps atrophy (Berchuck et al., 1990).  
ACLR is a highly successful procedure, yet there are residual instabilities that still occur 
post surgery (Woo et al., 2002); this may be due to the surgical procedure itself, or due to a 
combination of the surgery and rehabilitation (Brandsson et al., 2002; Papannagari et al., 
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2006). This means that some patients do not return to their pre-injury sports level post 
surgery. However, for those who do return to sport the re-rupture rate is high (Paterno et 
al., 2010). Furthermore, ACLR surgery does not consistently reduce other degenerative 
changes at the joint, such as of the meniscus and cartilage. Researchers have suggested that 
this could be a consequence of the knee joint kinematics that have not been fully restored 
by the reconstructive surgery and rehabilitation.  
Based on the geometry of the knee joint of the patients, an alternative method to restore 
knee stability is by activating the hamstrings, especially the biceps femoris long head 
(BFLH), at the appropriate point in the gait cycle. An electromyographic (EMG) study of 
ACLD and ACLR patients found an increased activity of the biceps femoris muscle that 
indicates a protective mechanism (Ciccotti et al., 1994), protecting the ACL reconstruction 
and protecting the knee from elevated internal rotation torques and anterior shear; when a 
posterior force is applied by activating the BFLH, external rotation of the tibia occurs and 
internal rotation torque is reduced. This is evidenced in clinical studies that show that ACL 
copers stabilize their knees by increased their co-contraction of hamstrings (Alkjaer et al., 
2003; Boerboom et al., 2001), however, one study disputes this (Rudolph et al., 2001). The 
interplay between knee stabilisation and musculoskeletal system restraint with functional 
electrical stimulation (FES) of the BFLH is not known for ACLD and ACLR patients. The 
effect of activation of BFLH with FES has the potential to reduce the knee instability of 
these patients. As described previously in this thesis (Chapter 3), another variable of 
interest with respect to BFLH activation is gait speed (Arnold et al., 2013) (Czerniecki et 
al., 1988) as hamstring muscle forces increase with walking speed (Neptune et al., 2005) 
and, therefore, the activation of BFLH with FES is possibly influenced by the gait speed. 
Also, gluteus maximus and gluteus medius are muscles that support the whole body during 
mid stance phase (Anderson et al., 2003) and the results of Chapter 4 show that gluteus 
maximus muscle forces increase with increased activation of BFLH.  
In Chapter 3, the selective activation of BFLH was able to reduce the anterior tibial shear 
and tibial internal rotation torque at the knee in healthy subject during early stance phase. 
In Chapter 4, the modified musculoskeletal model which was introduced in Chapter 3 was 
validated by evaluating the measured EMG signal of the gluteus maximus while activating 
the BFLH with FES. In this chapter, the validated musculoskeletal model is used to predict 
and analyse the effect of activating during stance phase BFLH with FES in three groups: 
ACLD patients, ACLR patients, and control group.  
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The aims of this chapter are to: 
1. simulate the ACLD and ACLR behaviour during stance phase using the 
validated musculoskeletal model (Chapter 4);  
2. investigate the effectiveness of activating BFLH using FES in increasing knee 
stability in ACLD and ACLR subjects; and 
3. compare knee stability between the control healthy group and the two patient 
groups. 
5.2 Materials and Methods 
Subject recruitment and selection 
This pilot study was approved by the Health Research Authority (HRA), following a 
submission to the HRA, attendance at the London - Queen Square Research Ethics 
Committee and confirmation that Imperial College Healthcare NHS Trust and Imperial 
College London could host this study. Full details are provided in Appendix A. Subjects 
were recruited through posters at Imperial College London: South Kensington Campus, St 
Mary’s Hospital Campus and Charing Cross Hospital Campus. The participating surgeons 
provided the clinical assessment of the state of the patient, as either ACLD or ACLR, 
confirmed by medical imaging (magnetic resonance imaging; MRI). Standard clinical 
decision-making took place prior to participating in the study and the study did not 
influence any treatment. The study inclusion criteria were that:  
either the injury or the ACL reconstruction surgery had to have occurred a 
minimum of 6 months prior to joining the study, as this is appropriate rehabilitation 
time post ACL reconstruction (Devita et al., 1998); and 
subjects must be aged between 18 and 60 years. 
The exclusion criteria were: 
any known allergy to adhesives; 
any psychiatric illness that limits the ability to give informed consent; 
pregnancy; 
patients with implanted electronic device (for example, cardiac demand 
pacemakers) unless under specialised medical supervision; 
poorly controlled epilepsy; and  
known musculoskeletal lower limb conditions other than ACL deficiency.  
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Participant information sheet and consent forms were then emailed to the patients who met 
the inclusion and exclusion criteria. They were given at least 24 hours to decide whether or 
not to participate in this study. Patients who agreed to participate were later contacted by 
the researcher to set the date and time for the study at which point signed informed consent 
was taken. Participants were free to withdraw at any time. 
Eight patients (7 male, 1 female; mean height 1.76 ± 0.06 m; mass 79.8 ± 11.5 kg; age 
27.25 ± 5.91) participated in this study. Eight healthy control subjects were selected who 
closely matched the patient group’s height, mass and age (6 male, 2 female; mean height 
1.76 ± 0.13 m; mass 76.28 ± 13.21 kg; age 28.5 ± 3.70 years). The patients consisted of: 4 
subjects with unilateral ACLD and 4 subjects with unilateral ACLR. The anthropometric 
data of patients and control subjects are shown in Table 5.1 and Table 5.2.  
Table 5.1 Patients’ anthropometric data  
Patient Type of 
injury 
Gender  Age 
(Year) 
Height 
(m) 
Mass 
(kg) 
Injury 
date 
Experiment 
date 
Duration time 
between injury/ 
surgery 
(months) 
ACLD group  
1 ACLD1 
(Full tear) 
Male 33 1.63 72.5 08.2016 17.01.2017 6 
2 ACLD2 
(Partial tear) 
Male 30 1.77 79.5 12.2015 11.01.2017 24 
3 ACLD3 
(Full tear) 
Male 29 1.90 80.0 03.2016 28.01.2017 10 
4 ACLD4 
(Partial tear) 
Male 21 1.72 75.2 04.2016 27.07.2017 15 
Mean (ACLD) 28.25 1.75 76.80  -  - 13.75 
SD (ACLD) 5.12 0.11 3.59  -  - 7.76 
ACLR group (all hamstrings grafts)  
5 ACLR1 Male 28 1.77 80.0 2011 18.01.2017 72 
6 ACLR2 Male 21 1.76 95.7 08.2016 14.02.2017 6 
7 ACLR3 Female 25 1.68 68.8 03.2015 16.03.2017 24 
8 ACLR4 Male 35 1.81 74.7 2003 02.06.2017 168 
Mean (ACLR) 27.25 1.76 79.8 - - 67.5 
SD (ACLR) 5.91 0.06 11.5 - - 72.6 
Mean all patients 
(ACLD and ACLR) 27.75 1.75 78.3 - - 40.6 
SD patients 
(ACLD and ACLR) 5.15 0.08 8.08 - - 55.7 
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Table 5.2  Control subjects’ anthropometric data  
Control subject Gender Age (Year) Height (m) Mass (kg) 
1 Male 26 1.89 100.9 
2 Male 31 1.63 62.7 
3 Female 30 1.53 70.8 
4 Male 28 1.77 68.2 
5 Male 26 1.83 92.0 
6 Female 25 1.73 68.4 
7 Male 26 1.82 71.2 
8 Male 36 1.92 76.0 
Mean 28.5 1.76 76.28 
SD 3.70 0.13 13.21 
 
Parametric one–way analysis of variance (ANOVA) for normally distributed data with 
equal error variances and nonparametric Kruskal Wallis tests for other data were used to 
test the null hypothesis that the three groups (ACLD, ACLR, control) means were equal 
with respect to height, mass and age.  Normality was tested using the Shapiro Wilk’s test 
and Levene’s test was used to test for equal error variances. Based on these tests, height 
and age were normally distributed and mass were not normally distributed (Table 5.3). 
Therefore, for height and age ANOVA was used and for mass the Kruskal-Wallis test was 
used to test for statistical difference between the groups. No statistical differences were 
found (Table 5.4). 
Table 5.3 Testing normality of data for height, mass and age for ACLD, ACLR and control groups using 
Shapiro Wilk’s test and Levene’s test 
3 groups Shapiro Wilk’s (p-value)  Levene’s (p-value) 
Height 0.728 0.312 
Mass 0.050 0.238 
Age 0.152 0.323 
 
Table 5.4 Testing for statistical difference of height, mass and age between ACLD, ACLR and control groups 
(using ANOVA for height and age and Kruskal-Wallis for mass) 
3 groups ANOVA (p-value) Kruskal-Wallis (p-value) 
Height 0.983 - 
Mass - 0.513 
Age 0.703 - 
The study was divided into two parts: in vivo physical experiments and computational 
musculoskeletal modelling.  
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In vivo experiments 
The experimental protocol was similar to the protocol for Chapters 3 and 4. The 
experiment took place in the motion lab in the Royal School of Mines at the Imperial 
College London South Kensington Campus. On arriving in the lab, the height and mass of 
the subjects were measured. Retro-reflective markers were placed on lower limb landmarks 
and three-dimensional marker trajectories (as per Chapter 3, Table 3.2) were measured at 
200 Hz using a 10-camera motion capture system (Vicon Motion Systems Ltd, Oxford, 
UK).  
The safety guidelines for conducting FES were carefully explained to the subjects 
including how to halt FES stimulation during the study. The FES electrodes were attached 
over the BFLH as follows: one FES electrode was attached at the distal part of the muscle 
and the other electrode was placed at the centre, with a distance of two hand widths 
between them (as in Chapter 3, Figure 3.6). FES was set to 40 Hz and 40mA of current 
stimulation. These levels were chosen as in Chapter 3, where the FES was able to reduce 
the anterior shear force and the internal rotation torque. The surface stimulation electrode 
used was 7 cm in diameter. Each subject was set to a different level of pulse widths (with 
the average level of 4.22, maximum level 6 and minimum level 3) according to their 
tolerance of the stimulation level. 
Subjects performed at least five trials of walking at a self-selected pace on a walkway with 
FES (FES gait) and without FES (normal gait). The walkway contained a force plate 
(Kistler Type 9286BA, Kistler Instrument AG, Winterthur, Switzerland) to measure 
ground reaction force. Control subjects walked on the walkway so that their right limb 
struck the force plate. Patient subjects stepped on the force plate with their affected (i.e. 
injured or reconstructed) limb. GRFs and EMG signals were simultaneously measured at 
1000 Hz from the force plate and EMG system (Delsys, Trigno Wireless EMG system, 
USA). In this pilot study, the last three trials were chosen for analysis as this represents the 
trials where the subjects had the greatest opportunity to adapt to the walking task. 
The stimulation of the FES current was set to start with 1 second of ramp up, followed by 4 
seconds of maximum current level and then ending with 1 second of ramp down. The 
current was set to an asymmetrical biphasic waveform, because this gives stronger 
contraction compared to the symmetrical biphasic (Lynch et al., 2008). The stimulator was 
manually started by the subject and timed so that the stimulation current was at its 
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maximum value when the right foot stepped on the force plate, through heel strike and toe 
off.  
Lower Limb Musculoskeletal model 
The lower limb musculoskeletal model was used as described in Chapters 3 and 4.  
As for those chapters, the standard cost function was used for the activity without using the 
FES. To simulate the stimulation of the FES during activities towards the BFLH in the 
revised optimisation, the muscle force of BFLH was set as a constant value, c, where c was 
set to 0.2 as the mean value found in Chapter 3 that reduced the anterior shear force to zero 
and the internal rotation torque to zero. 
Data Analysis 
The anterior tibial shear force, internal tibial rotational torque, gait speed, gluteus medius 
and gluteus maximus muscle activations were averaged over three trials and presented as 
mean values in the tibial coordinate frame. The gluteus medius and gluteus maximus 
muscle activations were predicted from the model. The anterior tibial shear force, internal 
tibial rotational torque, gluteus medius and gluteus maximus muscle activations were 
normalised to body weight (BW). The stance phase was expressed in a 0-100% duration 
with a step interval of 1% using cubic spline data interpolation (MATLAB, the Mathworks 
Inc., Natick, USA). To test the hypothesis that the knee peak internal tibial rotational 
torque, peak anterior tibial shear force and speed were reduced and gluteus medius and 
gluteus maximus muscle activations were increased by applying FES to the BFLH, the gait 
data without FES (normal gait) and with FES (FES gait) for all three groups were 
compared using the non-parametric one way ANOVA, Kruskal-Wallis test at α=0.05. 
When significant differences were observed, Tukey’s post hoc test was used with 
Bonferroni correction. All tests were calculated in MATLAB (R2015b, The Mathworks 
Inc., Natick, MA).  
Sprague and Geers metric was used to calculate the difference in internal rotational torque 
in terms of the magnitude (M), phase (P) and combined (C) errors between groups. This 
method was devised as a modification of Geers’ metric to enable the comparison of 
measured and experimental curves in biomechanics. Based on the Sprague and Geers 
metric, m(t) is the measured history and c(t) is the calculated history. The time integrals are 
defined as follows (Schwer, 2007): 
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where 
21
ttt  is the time interest response for the waveforms.  
In this pilot study, the internal rotational torque of the patient group (ACLD or ACLR) was 
set as the measured curve, m(t) and the internal rotational torque of the control group was 
set as the calculated curve, c(t). The M, P and C values are defined as follows (Schwer, 
2007; Sprague et al., 2003): 
1/ 
mmCC
vvM                Equation 5.2 
which is insensitive to phase differences because it is based upon the area under the 
squared response histories, with the –1 providing a zero metric value when the two areas 
are identical;    
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v
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              Equation 5.3 
which is insensitive to magnitude differences (Sprague et al., 2003); and 
22
PMC   
This formula therefore enables magnitude and phase metrics to be combined (Geers, 1984). 
If values of M and P are below 0.20 then this indicates that there is a high level of 
similarity between the two waveforms. Values for M and P between 0.20-0.30 indicate that 
there is a medium level of similarity the two waveforms.  Values higher than 0.30 indicate 
that there is low level of similarity between the two waveforms (Geers, 1984). Positive M 
indicates that the m(t) waveform is lagging relative to the c(t) waveform. 
5.3 Results  
Internal rotation torque 
All the curves of the internal rotation torques for control, ACLD and ACLR groups during 
normal gait and FES gait are shown in Figure 5.1. The peak values of the internal rotation 
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torque for all groups are shown in Table 5.5. There was a significant difference between 
the three groups for peak internal rotation torque during normal gait (p=0.040). There was 
a significant difference in peak internal rotation torque between the control group during 
normal gait and the ACLD and ACLR groups during FES gait (p=0.038). 
Table 5.5 Peak internal rotation torque (Nm/BW) for 8 control subjects, 4 ACL deficient subjects and 4 ACL 
reconstructed subjects during stance phase (*p< 0.05) 
Subject 
Internal rotation torque (Nm/BW) 
Normal gait (p=0.04)* FES gait  
Control* ACLD ACLR Control ACLD* 
ACLR 
(p=0.038)* 
1 0.0079 0.0009 0.0015 0.0087 0.0011 0.0012 
2 0.0025 0.0006 0.0025 0.0018 0.0001 0.0027 
3 0.0017 0.0030 0.0001 0.0017 0.0019 0.0001 
4 0.0032 0.0021 0.0016 0.0031 0.0016 0.0020 
5 0.0015 - - 0.0014 - - 
6 0.0031 - - 0.0028 - - 
7 0.0032 - - 0.0034 - - 
8 0.0032 - - 0.0021 - - 
Mean 0.0033 0.0016 0.0014 0.0031 0.0012 0.0015 
SD 0.0020 0.0011 0.0010 0.0023 0.0008 0.0011 
 
Table 5.5 shows that the peak internal rotation torque for the control group in normal gait 
(mean = 0.0033±0.0020 Nm/BW) is higher than the ACLD group (mean = 0.0016±0.0011 
Nm/BW; p=0.073) and ACLR group (mean = 0.0014±0.0010 Nm/BW; p=0.048) in normal 
gait (Figure 5.2). The internal rotation torques of the control group (Figure 5.3) and the 
ACLD group (Figure 5.4) are higher in normal gait compared to FES gait by 4.69% and by 
27.78% but the internal rotational torque of the ACLR group (Figure 5.5) is higher in FES 
gait compared to the normal gait by 6.18% (Table 5.6).  
Table 5.6 Percentage difference between mean peak internal rotation torque in normal gait and FES gait for 
all groups 
Group Control ACLD ACLR 
Differences -4.69% -27.78% 6.18% 
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Figure 5.1 Internal rotation torque (Nm/BW) (mean ± SD) for control (n=8), ACLD (n=4) and ACLR (n=4) 
groups during normal gait and FES gait 
 
Figure 5.2 Internal rotation torque (Nm/BW) (mean ± SD) for control (n=8), ACLD (n=4) and ACLR (n=4) 
groups during normal gait 
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Figure 5.3 Internal rotation torque (Nm/BW) for control group (mean ± SD,n=8) during normal gait and FES 
gait 
 
Figure 5.4 Internal rotation torque (Nm/BW) for ACLD group (mean ± SD, n=4) during normal gait and FES 
gait 
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Figure 5.5 Internal rotation torque (Nm/BW) for ACLR groups (mean ± SD, n=4) during normal gait and 
FES gait 
Sprague and Geers metric (Internal rotation torque) 
Internal rotation torque curve of the control group during normal gait (HN) and the internal 
rotation torque curve of the ACLR group during FES gait (RF) were highly similar in 
magnitude (M=0.09) but highly dissimilar in terms of phase (P=0.54; Table 5.7). Internal 
rotation torque of the control group during normal gait (HN) and the internal rotation 
torque of the ACLD group during FES gait (DF) were highly dissimilar in terms of 
magnitude (M=0.39) and phase (P=0.52; Table 5.7).  
There are also high levels of differences in the internal rotation torque curves between the 
ACLD group during normal gait (DN) and ACLD group during FES gait (DF) (P=0.59) 
and also with ACLR group during FES gait (RF) (P=0.58; Table 5.7). 
There are high levels of similarity between the internal rotation torque curve of the ACLR 
during normal gait (RN) and ACLR group during FES gait (RF) (Table 5.7) in terms of 
magnitude error (M=0.07) but not in terms of the phase error (P=0.59). 
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Table 5.7 Magnitude error (M), Phase error (P) and combined error (C) (Sprague and Geers’ metric) for the 
comparison of internal rotation torque of the measured waveform, m(t) and calculated waveform, c(t) 
Measured waveform, m(t) HN DN RN 
Calculated waveform, c(t)  DF RF DF RF RF 
M 0.39 0.09 -0.17 -0.34 -0.07 
P 0.52 0.54 0.59 0.58 0.59 
C 0.65 0.55 0.61 0.67 0.59 
 
Anterior shear force 
Anterior shear forces of the three groups are shown in Figure 5.6. Peak values of anterior 
shear forces are shown in Table 5.8. There is a significant different between the peak 
anterior shear force in the control group during normal gait and the ACLD and ACLR 
during FES gait (p=0.002). There is a higher peak anterior shear force in the control group 
during normal gait compared to the ACLD group during FES gait (p=0.003). 
 
Figure 5.6 Mean shear force (BW) curves (mean ± SD) for 8 control healthy subjects, 4 ACLD subjects and 4 
ACLR subjects 
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Table 5.8 Peak anterior shear force (BW) for 8 control subjects, 4 ACL deficient subjects and 4 ACL 
reconstructed subjects (* p< 0.05) 
Subject 
Anterior shear force (BW) 
Normal gait  FES gait  
Control* ACLD ACLR Control ACLD* 
(p=0.003)* 
ACLR 
(p=0.002)* 
1 0.238 0.378 0.246 0.152 -0.517 -0.013 
2 0.461 0.190 0.039 0.034 -0.166 -0.093 
3 0.325 0.468 0.329 0.006 -0.047 -0.071 
4 0.229 0.180 0.133 0.053 -0.255 0.064 
5 0.013 - - 0.028 - - 
6 0.383 - - 0.006 - - 
7 0.324 - - 0.052 - - 
8 0.242 - - 0.033 - - 
Mean 0.277 0.304 0.187 0.045 -0.246 -0.028 
SD 0.125 0.123 0.110 0.043 0.173 0.061 
 
The anterior shear force curves for all ACLD subjects during normal and FES gait are 
shown in Figure 5.7, Figure 5.8, Figure 5.9 and Figure 5.10. The anterior shear force 
curves for all ACLR subjects during normal and FES gaits are shown in Figure 5.11, 
Figure 5.12, Figure 5.13 and Figure 5.14. 
 
Figure 5.7 Shear force (BW) (mean ± SD) for subject ACLD1 (Full Tear) 
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Figure 5.8 Shear force (BW) (mean ± SD) for subject ACLD2 (Partial Tear) 
   
 
Figure 5.9 Shear force (BW) (mean ± SD) for subject ACLD3 (Full Tear) 
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Figure 5.10 Shear force (BW) (mean ± SD) for subject ACLD4 (Partial Tear) 
 
Figure 5.11 Shear force (BW) (mean ± SD) for subject ACLR1 
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Figure 5.12 Shear force (BW) (mean ± SD) for subject ACLR2 
 
Figure 5.13 Shear force (BW) (mean ± SD) for subject ACLR3 
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Figure 5.14 Shear force (BW) (mean ± SD) for subject ACLR4 
 
Speed  
The speed (as calculated from the stance phase only) results are shown in Table 5.9. 
There is a significant difference in speed between the control group during normal gait and 
the ACLD and the ACLR groups during FES gait (p=0.029). There is significantly higher 
speed in the control group during normal gait compared to the ACLD group during FES 
gait (p=0.023). There is a significant difference in speed between groups in FES gait 
(p=0.047) and there is significantly higher speed in the control group during FES gait 
compared to the ACLD group during FES gait (p=0.004).  
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Table 5.9 Mean speed (m/s) of 8 control subjects, 4 ACL deficient subjects and 4 ACL reconstructed subjects 
(*p< 0.05) 
Subject Normal gait FES gait (p=0.047)* 
Control* 
ACLD 
(p=0.021)* 
ACLR 
 
Control 
ACLD 
(p=0.023)* 
ACLR 
(p=0.029)* 
1 0.32 0.20 0.27 0.27 0.20 0.23 
2 0.39 0.24 0.29 0.33 0.20 0.25 
3 0.28 0.33 0.40 0.23 0.29 0.35 
4 0.31 0.23 0.36 0.29 0.21 0.33 
5 0.35 - - 0.31 - - 
6 0.32 - - 0.33 - - 
7 0.40 - - 0.39 - - 
8 0.33 - - 0.29 - - 
Mean 0.34 0.26 0.33 0.31 0.23 0.29 
SD 0.04 0.06 0.06 0.05 0.04 0.06 
 
Table 5.10 Percentage difference between mean speed in normal gait and FES gait for all groups 
Group Control ACLD ACLR 
Differences -9.63% -10.0% -12.12% 
 
The control group (0.34±0.04m/s) walks faster than the ACLD (0.26±0.06m/s) group in 
normal gait (Table 5.9; p = 0.021). The control group, the ACLD group and the ACLR 
group walk slower in FES gait compared to normal gait by 9.63% in control group 
(p=0.020), 10.0% in ACLD group and by 12.12% in ACLR group (Table 5.10). 
Gluteus maximus muscle activation 
The mean gluteus maximus muscle activation predicted from the model for the three 
groups are shown in Figure 5.15, Figure 5.16 and Figure 5.17. There is a significant 
difference in the first peak gluteus maximus muscle activation between groups for FES gait 
(p=0.038). There is significantly lower first peak gluteus maximus muscle activation in 
FES gait for the ACLD group compared to the ACLR group (p=0.043). The mean first 
peaks of gluteus maximus muscle activation during stance phase for the three groups are 
shown in Table 5.11.  
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Table 5.11 Peak gluteus maximus muscle activation for 8 control subjects, 4 ACLD subjects and 4 ACLR 
subjects (*p< 0.05) 
Subject 
Gluteus maximus muscle activation 
Normal gait  FES gait (p=0.038)* 
Control ACLD ACLR Control ACLD* 
ACLR 
(p=0.043)* 
1 0.0738 0.0706 0.0262 0.1058 0.0598 0.0641 
2 0.0411 0.0120 0.0706 0.1069 0.0211 0.1115 
3 0.0611 0.0646 0.0928 0.1080 0.0456 0.1154 
4 0.0889 0.0583 0.0444 0.0906 0.0971 0.1137 
5 0.0409 - - 0.1024 - - 
6 0.0809 - - 0.1577 - - 
7 0.0599 - - 0.0991 - - 
8 0.0408 - - 0.0000 - - 
Mean 0.0609 0.0514 0.0585 0.0963 0.0559 0.1012 
SD 0.0191 0.0267 0.0293 0.0438 0.0318 0.0248 
 
 
 
Figure 5.15 Gluteus maximus muscle activation (mean ± SD) for 8 control subjects 
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Figure 5.16 Gluteus maximus muscle activation (mean ± SD) for 4 ACLD subjects 
 
Figure 5.17 Gluteus maximus muscle activation (mean ± SD) for 4 ACLR subjects 
Gluteus medius muscle activation 
The mean gluteus medius muscle activation for control, ACLD and ACLR subjects are 
shown in Figure 5.18, Figure 5.19 and Figure 5.20. There is a significant difference of the 
first peak gluteus medius muscle activation between groups for FES gait (p=0.014). There 
is significantly lower mean first peak gluteus medius muscle activation of the control 
group during normal gait (mean=0.1021±0.0180) compared to the ACLR group during 
FES gait (mean=0.1693±0.0928; p=0.018). The mean first peak curves of gluteus medius 
muscle activation during stance phase for the three groups are shown in Table 5.12. 
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Table 5.12  Peak gluteus medius activation for 8 control subjects, 4 ACLD subjects and 4 ACLR subjects 
(*p< 0.05) 
Subject 
Gluteus medius muscle activation 
Normal gait  FES gait (p=0.014)* 
Control* ACLD ACLR Control ACLD 
ACLR 
(p=0.018)* 
1 0.0708 0.0979 0.0938 0.0678 0.1234 0.1452 
2 0.0892 0.1014 0.1625 0.1256 0.1313 0.2026 
3 0.1041 0.0958 0.1286 0.1563 0.0650 0.1403 
4 0.1007 0.1051 0.1280 0.0865 0.1342 0.1891 
5 0.1040 - - 0.1532 - - 
6 0.1289 - - 0.1978 - - 
7 0.0976 - - 0.1033 - - 
8 0.1214 - - 0.0842 - - 
Mean 0.1021 0.1001 0.1282 0.1218 0.1135 0.1693 
SD 0.0180 0.0536 0.0710 0.0445 0.0643 0.0928 
 
 
 
Figure 5.18 Gluteus medius muscle activation (mean ± SD) for 8 control subjects 
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Figure 5.19 Gluteus medius muscle activation (mean ± SD) for 4 ACLD subjects 
 
Figure 5.20 Gluteus medius muscle activation (mean ± SD) for 4 ACLR subjects 
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There is a significant difference between groups in peak internal rotation torque. Post hoc 
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that there are high differences in internal rotational torque curves between all two groups in 
terms of phase as shown in Table 5.7. Table 5.5 shows that the patient groups have lower 
internal rotation torque compared to the control group in normal gait. This result is 
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shows that the BFLH stimulation with FES is able to reduce the internal rotation torque of 
the control group and the ACLD group but not in the ACLR group. This could be due to 
the ACLR group having tight ACL grafts which restricts the movement at the knee. 
Previous studies have shown that the surgical placement of the graft near to the central axis 
of the knee joint can have a significant effect on its resistance to rotatory loads (Kanamori 
et al., 2000; Woo et al., 2002; Yagi M, 2002). 
There is a significant difference in peak anterior shear force between the control group 
during normal gait and the ACLD and ACLR groups during FES gait. There is a higher 
peak anterior shear force in the control group during normal gait compared to the ACLD 
group during FES gait. This result shows that the FES is successfully contracting the 
BFLH and reduced the peak anterior shear force of the ACLD group more than the ACLR 
group. 
The FES stimulation of BFLH caused all groups to have slower gait compared to the 
normal gait. The control group has faster gait in normal gait and FES gait compared to the 
ACLD group in FES gait. The ACLD group has the slowest speed compared to other 
groups in both gaits. Table 5.9 shows that during normal gait the control group 
(0.34±0.04m/s) walks faster compared to the patient groups. This would suggest kinematic 
differences between these groups; these were not analysed in this study. BFLH stimulation 
slows down the walking speed of all groups (Table 5.10). 
The muscle activation results show that the ACLR group has the highest first peak gluteus 
muscle activation compared to the other groups. The FES stimulation of BFLH did not 
show any significant changes to the gluteus medius and gluteus maximus muscle activation 
of the ACLD group compared to other groups. 
5.4 Discussion 
ACL deficiency causes knee laxity in internal tibial rotation and anterior tibial translation. 
This is due to the shear and torque at the joint during activities of daily living not being 
adequately resisted by structures that can compensate for the ACL deficiency. 
Additionally, it is proposed that the joint position offset due to ACL deficiency increases 
the magnitude and effect of the shear and torque at the joint. The structures that may resist 
these loads include secondary ligamentous structures and muscles. BFLH is geometrically 
positioned to be able to apply posterior force on the tibia and increase the external 
rotational force to reduce the ACL deficient knee instability. Even ACLR patients may 
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have residual instabilities and, therefore, BFLH activation may also assist in these cases. 
This chapter tested, using a combined modelling and experimental approach, the 
hypothesis that activation of the BFLH can theoretically and practically reduce the anterior 
tibial shear, tibial internal rotation torque and speed of ACLD and ACLR subjects during 
the stance phase of gait. The hypothesis that activation of the BFLH can theoretically and 
practically increase the gluteus medius and gluteus maximus muscle activations is also 
discussed.  
Internal rotation torque 
There is a significant difference in the peak internal rotation torque between the three 
groups during normal gait (p=0.040). When stimulation of BFLH with FES is applied to 
the patient groups, they have a greater reduction in peak internal rotation torque compared 
to the control group (p=0.038). This indicates that FES reduces the internal rotation torque 
of both ACLD and ACLR patients.   
The peaks of the tibial internal rotational torque for the three groups (Figure 5.1) took 
place at similar time frame, around 20% of stance phase, which is the transition from the 
end of loading response (4-19% of stance phase) to the beginning of the mid stance phase 
(20-50% of stance phase). This result is different from a study which claimed that the 
internal tibial rotational torque is during heel strike (Andriacchi et al., 2005). It is 
important to understand that the four sequential sub-phases in stance phase (initial contact, 
loading response, mid stance and terminal stance) are further grouped into weight 
acceptance (initial contact and loading response) and single limb support (mid stance and 
terminal stance) tasks (Perry et al., 2010). This means that the peak value of the tibial 
internal rotational torque occurred at the point of functional task transition weight 
acceptance (from weight bearing stability because of the initial double stance period) to the 
single limb support (progression over the stationary foot where the other foot starts to lift 
for swing). This transition causes instability at the knee joint where the tibia rotates more 
than usual. Thus, the exact time to reduce the peak tibial internal rotational torque of the 
patients by activating BFLH with FES is during this transition time.  
Based on the Sprague and Geers’ metric calculations, there was a positive phase error 
between the control group and the patients groups which indicate that the peak internal 
tibial rotational torque of the ACLD and ACLR groups has a time lag relative to the 
control group (Table 5.7). This means that the patients need the BFLH activation earlier 
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than the control group to support the progression of the single limb that is supporting the 
whole body weight. As expected, the magnitude of phase errors between these groups are 
highly dissimilar (Table 5.7) indicate that the patients tend to limit their internal tibial 
rotational movement during stance phase.   
Surprisingly, there is no significant difference in peak internal rotation torque between the 
ACLD and ACLR groups during FES gait. This shows that the ACLR does not change 
much in terms of tibial internal rotation compared to the ACLD. However, there is phase 
error between the ACLD group during normal gait and ACLR group during FES gait 
which indicates that the ACLR group has a slight time lag relative to the ACLD group 
(Table 5.7).  
In summary, the activation of BFLH with FES is able to reduce the peak of internal 
rotation torque in both ACLD and ACLR patients and occurs during the transition from 
weight acceptance task to single limb support task.  
Anterior shear force 
There is a significant difference in peak anterior shear force between the control group 
during normal gait and the ACLD and ACLR groups during FES gait (p=0.002). The 
stimulation of BFLH with FES on the ACLD group has a significantly smaller peak 
anterior shear force compared to the control group during normal gait (p=0.003). However, 
there is no significant difference in peak anterior shear force between the control group 
during normal gait and the ACLR group during FES gait. FES for the ACLD has 
successfully reduced the anterior shear force more than the ACLR group (Figure 5.6). It is 
hypothesised that this is due to more lateral laxity at the knee joint for the ACLD group 
compared to the ACLR group. 
Based on the results obtained in this study, the peak of anterior shear force of all groups 
occurred during the transition from the weight bearing to single support limb task 
(approximately 20% of stance phase, Figure 5.6), similar to the occurrence of the peak of 
internal rotational torque. This corresponds to previous studies that found that the anterior 
shear force occurred during early stance phase (Lafortune et al., 1992) or during mid stance 
(Alkjaer et al., 2011; Gao et al., 2010). These results indicate that the activation of BFLH 
is needed most during this transition in order to stabilize the knee joint in both ACLD and 
ACLR patients. 
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It is interesting that patient ACLD1 (ACL full tear) (Figure 5.7) has a longer duration of 
anterior shear force compared to other ACLD subjects (Figure 5.8, Figure 5.9 and Figure 
5.10). During loading response (3-19% of stance phase), the knee is flexed for shock 
absorption (from the instant foot drop during initial contact) with the help of the heel as a 
rocker (Perry et al., 2010). The body weight is aligned over the forefoot at the end of the 
mid stance phase (20-50% of stance phase). This subject may have increased the time of 
knee flexion (loading response) before having full knee extension in mid stance in order to 
support the full body weight gradually (Gao et al., 2010) at the same time avoiding 
quadriceps contraction (Berchuck et al., 1990). Moreover, patient ACLD1 has a longer 
duration of anterior shear force compared to other ACLD subjects; this may be explained 
by the shorter time after injury of this patient compared to other ACLD subjects. However, 
this study does not analyse the knee flexion angle during stance phase and this would be a 
good future study. 
The spikes at the early stance phase in Figure 5.6 may be caused by co-contraction of other 
hamstrings muscles (biceps femoris short head, semitendinosus and semimembranosus - as 
has been shown by (Biscarini et al., 2013) during the activation of biceps femoris long 
head with FES. ACL deficient subject have been shown to have atypical hamstrings EMG 
profiles during stance phase (Boerboom et al., 2001).  
Speed 
The control group (0.34±0.04m/s) walks faster than the ACLD (0.26±0.06m/s) and ACLR 
(0.33±0.06m/s) groups in during normal gait (Table 5.9) and FES gait. This indicates that 
there is abnormality in the walking of the patients. The differences in FES gait can be 
explained by a number of factors, including that the FES activation was for the whole of 
the stance phase, including portions of the stance phase where an anteriorly directed shear 
force was not present and so the activation produced an elevated posterior shear force. In 
the future, the BFLH stimulation should be activated during the transition from the weight 
bearing to single support limb task. This would likely be more comfortable for the patient 
groups. The reason for overall reduction in walking speed for the patient groups even 
without FES can be explained from the literature in which it is known that they do not fully 
extend their knee during stance phase and so introduce a reduced stride length and slower 
gait (Gao et al., 2010).  
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Gluteus maximus and gluteus medius muscle activation  
Gluteus maximus and gluteus medius are muscles that support the whole body during the 
mid stance phase (Anderson et al., 2003; Winter et al., 1987),  whereby the peak of the 
tibial rotation torque and peak anterior shear force take place at the same time. During the 
mid stance phase, the first peak of both gluteus maximus and gluteus medius occurred. The 
high activation of BFLH is able to increase the gluteus maximus muscle activation which 
has been shown in Chapter 4. In this chapter, the stimulation of BFLH with FES is able to 
show that it affects the gluteus group muscle during mid stance.  
The first peak of gluteus maximus muscle activation is significantly lower for the ACLD 
than ACLR group during FES gait (p=0.043) and first peak of gluteus medius muscle 
activation is significantly lower for the control than ACLR group during FES gait 
(p=0.018). Among the three groups, the ACLD group has the lowest peak gluteus medius 
and gluteus maximus muscle activation during both normal and FES gait. The reason for 
this could be that the ACLD group do not fully extend their knee during mid stance in 
order to restrict the gluteus muscles to fully support the whole body. This has been 
proposed elsewhere in the literature (Berchuck, 1990). The whole body of ACLD patients 
could be supported by the gluteus group of the contralateral leg during mid stance.  
Limitations  
This study shows a small mean value of the internal rotation torque of the three groups 
during the normal and FES gait. The findings suggest that there is no significant difference 
of peak anterior shear forces between the control group during normal gait and the ACLR 
group during FES gait.  It may be that the study is underpowered to find a significant 
difference, and a power analysis could now be conducted to see what group sizes are 
required to follow on from this pilot study. Besides, there is a large gap in the duration 
time between the injury and surgery and the experiments were carried out at different times 
for both groups. Time and small sample size have an effect on the results of the test 
statistic used in this study.  However, this study did show that the activation of BFLH with 
FES is able to reduce the anterior shear force of ACLD and ACLR group during stance 
phase. This finding is probably due to the variable degree of laxity of the ligaments and the 
different anatomic configuration of the knee between the subjects.  
Comparing the knee instability of ACLD and ACLR leg with contralateral leg as a control 
could provide a better knowledge on the effect of the BFLH activation with FES. This is 
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because the compensatory strategy to stabilise the ruptured ACL could be supported by the 
contralateral leg. There is evidence that ACLD patients walk with a symmetrical gait that 
means that the unaffected limb reproduces the abnormal moment at the knee and at the hip 
(Berchuck et al., 1990). This would suggest that it may be possible that the activation of 
muscles on the contralateral leg could provide knee stability on the injured leg through 
creating a more physiological symmetrical gait.  
The musculoskeletal model used in this study is a non-subject specific model. The 
anatomical model in this study is taken from a healthy subject and thus this model does not 
comprehensively simulate the conditions of ACLD and ACLR. It is known that after the 
loss of the ACL function, the axis of internal rotation of the knee that is normally at the 
middle of the tibial plateau surface is shifted to the medial side of the tibia. However, to 
find the exact position of the axis of rotation for each individual is quite challenging 
because it varies between individuals. The different morphologies of the tibial plateau 
surface with convexities, concavities and differences in posterior slope between medial and 
lateral sides (Hashemi et al., 2008; Lankester et al., 2008), also make it difficult to locate 
the axis of rotation for each subject.  
Activating BFLH changes the movement pattern of other muscles and ligaments. For 
example, the medial collateral ligament (MCL) is the secondary stabiliser after ACL 
injury.  The iliotibial band also acts as an anterolateral stabiliser of the tibia (Kwak et al., 
2000), because of its attachment on the lateral tubercle of the tibia. These could all be 
investigated by looking at the changes in the activity of other muscles.  
Besides, it is also interesting to explore the lower limb muscle activity in the whole gait 
cycle because the original muscle activity of BFLH is only at the early stance phase but in 
this study the activation of BFLH was increased beyond its natural levels. It is also 
important to note that the external tibial rotation reduction at the end of the swing phase 
causes the anterior tibial shear reduced for the ACLD knee (Andriacchi et al., 2005). Thus, 
the transition between  swing phase and stance phase is also an important consideration in 
evaluating the ACLD knee (Beynnon et al., 2002). Figure 5.6 shows that after 80% of 
stance phase the posterior shear forces became elevated. This mirrors the results found in 
Chapter 3 (Figures 3.21-3.32). Therefore, to mitigate any detrimental posterior forces, the 
recommendation from this work would be that stimulation should stop after 80% of stance 
phase and should not extend for the whole of the stance phase. 
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In the future, kinematics data should also be analysed; this would enable comprehensive 
analyses of the effect of BFLH stimulation with FES in both ACLD and ACLR patients. 
The contralateral leg should also be analysed to enable the questions of symmetry in 
pathological gait to be assessed.  
5.5 Conclusion  
This pilot study has shown the potential for activation of BFLH to reduce knee instability 
in both internal rotational torque and the anterior shear force specifically during the 
transition from the loading response to the mid stance phase for both ACLD and ACLR 
subjects. Treatment with FES during walking activity could potentially provide better knee 
stability and performance for ACL deficient and ACL reconstructed patients. The model 
used in this study can be improved to be applied in designing a rehabilitation device or a 
device to stimulate the correct muscle at a predefined time that can be used to assist ACLD 
and ACLR patients in undergoing their gait activity.  
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CHAPTER 6   
Discussion and conclusions 
This chapter summarises the key findings from this thesis and places them in the context of 
other work in the field. Future work is proposed and discussed by way of specific 
alternative musculoskeletal pathologies that may benefit from selective muscle activation 
through FES as defined by musculoskeletal modelling.  
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6.1 Key findings 
This thesis has explored the ability of FES to provide knee stability for ACLD and ACLR 
patients through a series of three main studies utilising musculoskeletal modelling and in 
vivo studies. In Chapter 3, it was shown that the selective activation of the BFLH can 
reduce the tibial anterior shear force, a surrogate of ATT and the internal tibial rotational 
torque at the knee in healthy subjects. A musculoskeletal model was modified to enable 
this analysis to take place. The modelling cost function was modified from its standard 
form by assigning a weighting, c, to simulate BFLH stimulation. The peaks of reduction of 
tibial internal rotational torque occurred during weight acceptance, near full knee 
extension, which is the time when the ACL is loaded. The hamstrings on the medial side 
could also reduce anterior shear force and this has been shown in other modelling studies 
(Shelburne et al., 2005). The reduction of the tibial internal rotational torque also indirectly 
affects the value of the anterior shear force (More et al., 1993) as can be derived through a 
simple equivalent force analysis. The value of c for each subject that reduced anterior shear 
force to zero was found and the mean value of c across all was 0.208. According to Liu et 
al (2000), hamstring activation without FES has shown that 56% of the maximal hamstring 
muscle force could reduce the ATT to a normal level during the stance phase of gait. It is 
important to note that the knee joint force may increase by activating BFLH and thus 
provide additional stability at the knee through concavity-compression. The knee joint 
reaction force was not focussed in this chapter. However, based on a model by Catafalmo 
(2015), 50% stimulation of BFLH is more appropriate than 100% of BFLH stimulation 
because there will be less knee joint reaction force and could avoid further deterioration 
towards the surface of the tibia. The results from this chapter showed that the posterior pull 
of the extra activation of the BFLH by FES resulted in a slower speed than normal gait. 
The modified musculoskeletal model used in this chapter was then validated in Chapter 4. 
In Chapter 4, the muscle forces calculated from the musculoskeletal model were validated 
non-invasively using electromyography (EMG). To avoid the problem of EMG signals 
being affected by the FES currents, a pair of muscles which are located a distant to each 
other were selected. The knee flexor muscle, BFLH was chosen as the stimulated muscle 
and its compensatory muscle for hip extensor (Kendall et al., 1993; Perry et al., 2010), 
gluteus maximus, was chosen as the EMG measuring muscle. The results showed that 
there was no FES artefact affecting the EMG signals. This study has found statistical 
correlations between peak and impulse of gluteus maximus activation between modelling 
119 
 
and EMG signals which provide a level of validation for the algorithm used in the 
musculoskeletal model and show that FES stimulation potentially can be tuned to a level to 
achieve different outcomes. Both mean peak gluteus maximus muscle activation predicted 
from the models and mean peak gluteus maximus activity from EMG measurement 
occurred during mid stance (20-50% of stance phase); prior work has also shown that this 
takes place in mid stance (Winter et al., 1987). 
Interestingly, these results seem to contradict the literature which highlights that when the 
hamstrings action is reduced, the gluteus maximus activity should be increased during 
loading response to provide hip stability. In our study, the activation of BFLH caused the 
the gluteus maximus activity to increased. The reason for this could be because the BFLH 
and gluteus maximus actions are multi joint processes and there is a “sweet spot” of 
hamstrings activation that maintains a minimal gluteus maximus activation and if the 
hamstrings either over- or under-activate, then gluteus maximus has to provide 
compensation. A ‘sweet spot’ is a location at which maximum response can be produced 
due to a combination of factors and a given amount of effort.  The gluteus maximus and 
hamstrings are the hip extensor and knee flexors respectively and have increasing activity 
in late swing to control the forward movement of the swinging lower limb (Winter et al., 
1987). Moreover, the hip extensor muscles have two functions, firstly to decelerate the 
limb’s momentum in terminal swing to prepare for stance, and secondly to restrain the 
forward momentum of the pelvis and trunk as the limb is loaded (Perry et al., 2010). In 
addition, during stance phase, the primary muscles controlling the hip are the extensors and 
abductors, which include the gluteus maximus. The extra activation of the BFLH with FES 
in this study forced gluteus maximus activity to be activated from late mid swing through 
the loading response more than usual. As the hamstrings and gluteus maximus have a 
complementary role as the plantar flexors, this might also change not only the kinematics 
of the foot (Jonkers et al., 2003) but also of the knee and hip during early stance phase. 
Both BFLH and gluteus maximus also assist in lateral rotation of the tibia. These multi-
joint actions provide an explanation for why the extra activation of BFLH with FES 
contributes to such large changes to gluteus maximus muscle activity and demonstrate the 
complexity of this “sweet spot” of activation.  
The validated musculoskeletal model from Chapter 4 was used in Chapter 5 in a patient 
group. This study found that activation of BFLH with FES at the knee of the healthy, 
ACLD and ACLR groups was able to reduce the internal tibial rotational torque and 
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anterior tibial shear force specifically during the transition from the loading response to the 
mid stance phase and it could be applied to any type of ACLD and ACLR. 
This model of muscular function and joint stability at the knee with the selective 
application of FES can potentially be used to plan and implement rehabilitation treatment. 
For example, rehabilitation is accelerated at a certain period after injury or surgery and 
FES could be incorporated in a device that can be used to assist in this rehabilitation by not 
only improving musculature before a return to more vigorous activities, but also to assist in 
muscle control through selective activation at particular points during an activity. The may 
enable ACL non-copers to become ACL copers.  
6.2 The role of FES in rehabilitation  
Today FES is available as a rehabilitation treatment for various conditions including spinal 
cord injury (SCI), ACLD/ACLR, cerebral palsy (CP) and osteoarthritis (OA). 
 Spinal cord injury (SCI)  
SCI is caused by diseases that destroy the neurological tissue of the spinal cord which can 
result in a partial or total loss of sensory function, paralysis, or both to parts of the body 
below the level of the injury. Clinically, FES has been widely used to stimulate paralyzed 
or paretic muscles caused by upper motor neuron lesions experienced by SCI patients 
(Lynch et al., 2008).  
FES stimulates and contracts one or more muscles to exert torques about a joint. By 
modulating the intensity of stimulation delivered to the flexor and extensor muscles, the 
resulting joint angle can be controlled to actuate the joint in opposite directions (Lynch et 
al., 2008). Large numbers of FES rehabilitation robots have been introduced to assist the 
SCI and stroke patients in functional activities. For example, rehabilitation orthosis 
LOKOMAT (Jezernik et al., 2003) and a hybrid neuroprosthesis that uses an electric 
motor-based wearable exoskeleton (Alibeji et al., 2015). 
FES technology is designed to offer better mobility to the patients suffering from SCI. FES 
is now considered to be one of the safest technique to apply currents to stimulate various 
human organs (e.g. assistance with respiration, bowel/bladder activity or some return of 
upper or lower limb function) of the body which is disabled due to SCI (Hamid et al., 
2008). It is proven that the quality of life of SCI patients treated using FES increases due to 
restored mobility function. 
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The musculoskeletal modelling approach used in this thesis could also be applied to SCI, 
through the selective analysis of the effect of muscle stimulation on joint dynamics, joint 
mechanics, and muscle mechanics. However, the application of this approach to joints 
other than the knee would need validation; it is known that knee control is fundamentally a 
mechanically-mediated process that is amenable to musculoskeletal modelling, yet other 
joints may have other major factors driving the control of the joints and therefore 
musculoskeletal modelling might not be the most appropriate technique to assess FES 
stimulation.  
ACLD and ACLR  
Apart from SCI, FES is employed to restore quadriceps strength of the ACLD and ACLR 
patients. Quadriceps muscles are often affected by arthrogenic muscle inhibition and 
muscle atrophy after ACL reconstruction, which limits volitional contraction. To generate 
better quadriceps strength and improve knee functional outcome, voluntary exercise 
together with FES, which directly recruits the motor neurons, is highly recommended 
(Palmieri-Smith et al., 2008).  
The rehabilitation treatment for ACLD and ACLR is focussing more on strengthening the 
quadriceps of the injured leg compared to the hamstring. To strengthen the quadriceps with 
FES, patients need to attend three rehabilitation sessions per week until the quadriceps 
maximal volitional isometric contraction is 80% of the uninvolved side (Adams et al., 
2012). This thesis has proposed that this alone will not be able to provide stability to these 
patients, as the selective, timed, activation of the hamstrings can provide joint stability that 
wouldn’t be provided by quadriceps strengthening along. In fact, it may even be the case 
that quadriceps strengthening without hamstrings excitation (and, perhaps strengthening), 
could be detrimental.  
Cerebral Palsy (CP)  
FES is useful in CP treatment program to control selective muscle (Papavasiliou, 2009) or 
reducing spasticity of CP (Kerr et al., 2004). Children with CP are offered FES as an 
option for a treatment to achieve a direct “orthotic” effect during gait. Among FES 
functionality is to stimulate quadriceps to extend the knee during stance phase or to 
stimulate ankle dorsiflexors to lift the foot during swing phase. By employing FES within 
the treatment, the neural pathway will be improved. In long term, it reduces the tendency 
122 
 
for muscle atrophy and improved motor control (van der Linden et al., 2008). This 
improved motor control is tantalising and it follows that a hypothesis could be proposed 
that FES for ACLD and ACLR could improve motor control in the long run.  
Osteoarthritis (OA)  
Similar to ACLD, patients with osteoarthritis (OA) of the knee have quadriceps weakness 
and arthrogenic muscle inhibition. Knee OA is a painful condition causing disability and 
muscle weakness especially to the older people. FES combined with exercise routine could 
aid in increasing muscle strength. This leads to reduced pain, as well as decreased joint 
stiffness and muscle spasm (Durmus et al., 2007). 
OA patients usually undergo total knee arthroplasty (TKA) to reduce pain and improve 
knee function. Yet, TKA could cause weak quadriceps after surgery. Thus, to strengthen 
the quadriceps activation failure and weakness experienced by patients, exercise that 
emphasize on strong muscle contraction and clinical tools while facilitating muscle 
activation, such as biofeedback and FES, may be necessary (Stevens et al., 2003). 
Selective activation of muscles on the lateral aspect of the knee such as biceps femoris can 
also be used to delay medial knee osteoarthritis (Hodges et al., 2016) and prior 
musculoskeletal modelling work has shown that FES can altering joint loading at the knee 
to reduce the medial loading (Rane et al., 2016; Xu et al.). This selective muscle activation 
for OA is a direct comparison to the work presented in this thesis for ACLD and ACLR.  
6.3 FES and muscle learning  
It is known that there are synergistic relationships between ligaments and muscles in 
maintaining knee joint stability. The increasing length and tension in the ligament requires 
an increase in muscular force acting in the other direction in order to sustain joint stability. 
The sensory role of the ligaments via their inputs to the spinal cord motor units could 
provide balance to the antagonist muscle pair in an excitatory and inhibitory load. After 
ACL injury, this synergistic relationship between ACL and hamstring muscles might be 
reduced.  
Ligaments also provide a source of reflex arc to relevant muscles through 
mechanoreceptors. The mechanoreceptors within the ACL and other knee ligaments 
transmit afferent information that may be processed as a reflex with the purpose of 
contracting musculature to decrease forces at the knee. It has been shown that this reflex 
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arc can be re-established after ligament reconstruction surgery, suggesting that 
mechanoreceptor have re-innervated the grafted ACL allowing for more normalized 
afferent function. This finding provides evidence that an ACL reflex exists, and can have 
both an excitatory and inhibitory component. It may be that this can be recovered in ACLD 
patients; Solomonow (2006) found that after only a few days’ of use of a smart brace with 
FES, muscle re-learning occurs through which hamstring activation is elevated to prevent 
subluxation even if the ‘smart brace’ is deactivated. This tantalising result demonstrates 
that selective FES activation might be able to be used in rehabilitation only and might not 
be required for chronic use beyond a period of learning. This has been described as a 
“carry over” effect which occurs after stimulating a muscle with FES for a duration of time 
(Rushton, 2003), in which the ‘carry over’ effect may be short- or long-lasting. The study 
claimed that FES stimulation may somehow provide adaptive changes in cortical 
connectivity. This mechanism provides training or ‘learning’ of the muscles after 
stimulation by the FES (Waters, 1984).  In SCI patients, Rushton (2003) deduced that FES 
stimulation must be simultaneously combined with voluntary effort activating the residual 
through a damaged pyramidal motor system, to help promote restorative synaptic 
modifications of these patients. This mechanism also indicates that the electrical 
stimulation applied at rest alone would not be expected to be beneficial to “train” the 
muscles (Rushton, 2003). This explains why some patients are not successful in recovering 
their leg functional movement while using the electrical stimulator device (Rushton, 2003).  
6.4 Muscle learning and its application in medicine or physiotherapy  
Based on the literature, the FES is able to improve muscle strength, improve flexibility and 
range of motion of the affected limb and reducing the amount of spasticity in CP patients. 
The treatment of the patients needs to be follow up for days or months to make sure that 
the FES has completely restored the functional limb. As shown above, there is a high 
possibility that a muscle can ‘learn’ after stimulation with FES. The understanding of 
learning and the ‘carry over’ effect on muscle after the FES stimulation also can be applied 
in rehabilitation programmes. The muscle learning process involves sensory organ which 
can transmit afferent information to the nervous system. However, it is a challenging task 
to find the right muscle or sensory organ to be stimulated during any functional activity. It 
is also difficult to find the most suitable time to successfully ‘educate’ the muscle during 
any functional activity. The biopotential feedback (e.g. EMG) could assist in predicting the 
suitable muscle for stimulation muscle and the right time during any rehabilitation activity.  
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6.5 Conclusions  
The benefit of using FES in rehabilitation treatment has previously been shown in treating 
SCI, CP and OA and this work has expanded its potential utility still further. In this thesis, 
stimulating BFLH with FES was shown to be able to reduce the knee instability of ACLD 
and ACLR patients. Therefore, besides quadriceps, the rehabilitation treatment should 
focus on appropriate timed activation of the BFLH to improve the quality of life of 
patients. However, there are also other kinematic and kinetic changes to the lower limb 
during the FES stimulation that should be taken into consideration, these include speed of 
motion, joint reaction forces, and forces in other muscles. Harnessing the muscle ‘learning’ 
effect through FES stimulation is a tantalising prospect to improve and accelerate the 
rehabilitation treatment process and this should be further investigated.  
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APPENDIX B : Gluteus maximus muscle activations predicted from 
modelling and the measured EMG. These results are summarised in Chapter 
4.  
 
Figure B.1 Gluteus maximus model predictions of subject 1 in normal walking and FES applied walking 
 
Figure B.2 Gluteus maximus EMG measurement of subject 1 in normal walking and FES applied walking 
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Figure B.3 Gluteus maximus model predictions of subject 2 in normal walking and FES applied walking 
 
Figure B.4 Gluteus maximus EMG measurement of subject 2 in normal walking and FES applied walking 
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Figure B.5 Gluteus maximus model predictions of subject 3 in normal walking and FES applied walking 
 
Figure B.6 Gluteus maximus EMG measurement of subject 3 in normal walking and FES applied walking 
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Figure B.7 Gluteus maximus model predictions of subject 4 in normal walking and FES applied walking 
 
Figure B.8  Gluteus maximus EMG measurement of subject 4 in normal walking and FES applied walking 
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Figure B.9 Gluteus maximus model predictions of subject 5 in normal walking and FES applied walking 
 
Figure B.10 Gluteus maximus EMG measurement of subject 5 in normal walking and FES applied walking 
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Figure B.11 Gluteus maximus model predictions of subject 6 in normal walking and FES applied walking 
 
Figure B.12 Gluteus maximus EMG measurement of subject 6 in normal walking and FES applied walking 
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Figure B.13 Gluteus maximus model predictions of subject 7 in normal walking and FES applied walking 
 
Figure B.14 Gluteus maximus EMG measurement of subject 7 in normal walking and FES applied walking 
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Figure B.15 Gluteus maximus model predictions of subject 8 in normal walking and FES applied walking 
 
Figure B.16 Gluteus maximus EMG measurement of subject 8 in normal walking and FES applied walking 
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Figure B.17 Gluteus maximus model predictions of subject 9 in normal walking and FES applied walking 
 
Figure B.18 Gluteus maximus EMG measurement of subject 9 in normal walking and FES applied walking 
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Figure B.19 Gluteus maximus model predictions of subject 10 in normal walking and FES applied walking 
 
Figure B.20 Gluteus maximus EMG measurement of subject 10 in normal walking and FES applied walking 
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Figure B.21 Gluteus maximus model predictions of subject 11 in normal walking and FES applied walking 
 
Figure B.22 Gluteus maximus EMG measurement of subject 11 in normal walking and FES applied walking 
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Figure B.23 Gluteus maximus model predictions of subject 12 in normal walking and FES applied walking 
 
Figure B.24 Gluteus maximus EMG measurement of subject 12 in normal walking and FES applied walking 
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Figure B.25 Gluteus maximus model predictions of subject 13 in normal walking and FES applied walking 
 
 
Figure B.26 Gluteus maximus EMG measurement of subject 13 in normal walking and FES applied walking 
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Figure B.27 Gluteus maximus model predictions of subject 14 in normal walking and FES applied walking 
 
 
Figure B.28 Gluteus maximus EMG measurement of subject 14 in normal walking and FES applied walking 
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Figure B.29 Gluteus maximus model predictions of subject 15 in normal walking and FES applied walking 
 
 
Figure B.30 Gluteus maximus EMG measurement of subject 15 in normal walking and FES applied walking 
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